<SEC-DOCUMENT>0001140361-25-038797.txt : 20251021
<SEC-HEADER>0001140361-25-038797.hdr.sgml : 20251021
<ACCEPTANCE-DATETIME>20251021142745
ACCESSION NUMBER:		0001140361-25-038797
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251021
DATE AS OF CHANGE:		20251021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251406558

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20057478_424b2.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html style="font-family: Arial; font-size: 9pt; text-align: left;">
  <head>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff">
  <div style="font-size: 9pt;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z56ed5f8a36984b6d87cc983665007b3b">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="font-size: 6pt;">Pricing Supplement dated October 20, 2025 to the</div>
              <div style="font-size: 6pt;">Product Supplement MLN-ES-ETF-1 dated February 26, 2025 and</div>
              <div style="font-size: 6pt;">Prospectus Dated February 26, 2025</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right; margin-right: 4.25pt; font-size: 6pt;">Filed Pursuant to Rule 424(b)(2)</div>
              <div style="text-align: right; font-size: 6pt;">Registration Statement No. 333-283969</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z22aa0e5117d440a9959b6a9b88932532">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div><img height="51" width="56" src="image0.jpg"></div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: center; font-size: 7.5pt; font-weight: bold;">The Toronto-Dominion Bank</div>
              <div style="text-align: center; font-size: 7.5pt; font-weight: bold;">$500,000</div>
              <div style="text-align: center; margin-right: 22.5pt; margin-left: 27pt; color: rgb(0, 0, 0); font-size: 7.5pt; font-weight: bold;">Autocallable Contingent Interest Barrier Notes with Memory Interest</div>
              <div style="text-align: center; margin-right: 22.5pt; margin-left: 27pt; color: rgb(0, 0, 0); font-size: 7.5pt; font-weight: bold;">Linked to the Least Performing of the shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, the shares of the
                Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
              <div style="text-align: center; margin-right: 22.5pt; margin-left: 27pt; font-size: 7.5pt; font-weight: bold;"><font style="color: rgb(0, 0, 0);">and the shares of the SPDR</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> S&amp;P 500</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> ETF Trust, Series 1 </font>Due November 4, 2026</div>
              <div style="text-align: center; font-size: 7.5pt; font-weight: bold;">Senior Debt Securities, Series H</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; font-family: Arial; font-size: 6pt; font-weight: bold;">General</div>
      <div> </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze25d48cf776c4e0a8ec307a429c5a422">

            <tr>
              <td style="width: 13.5pt; vertical-align: top; font-size: 6pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-size: 6pt;">The Notes are designed for investors who (i) wish to receive a Contingent Interest Payment (as defined below), plus any previously unpaid Contingent Interest Payments, if on any Review Date the Closing Price of
                  <font style="font-weight: bold;">each</font> Reference Asset (as defined below) is greater than or equal to its Barrier Price (as defined below), (ii) are willing to accept the risk of losing a significant portion or all of their
                  Principal Amount and of not receiving any Contingent Interest Payments over the term of the Notes and (iii) are willing to forgo fixed interest and dividend payments. Contingent Interest Payments should not be viewed as periodic interest
                  payments. <font style="font-weight: bold;">Investors will be exposed to the market risk of each Reference Asset and any decline in the price of one Reference Asset may negatively affect their return on the Notes and will not be offset or
                    mitigated by a lesser decline or any potential increase in the price of any other Reference Asset.</font></div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z04a889a1c6ae49c29a63e0c6faa186a4">

            <tr>
              <td style="width: 13.3pt; vertical-align: top; font-size: 6pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-size: 6pt;">The Notes will be automatically called prior to the Maturity Date if the Closing Price of <font style="font-weight: bold;">each</font> Reference Asset is greater than or equal to its Initial Price on any Review
                  Date other than the Final Review Date. If the Notes are not automatically called and the Closing Price of <font style="font-weight: bold;">any</font> Reference Asset on the Final Review Date (its &#8220;Final Price&#8221;) is less than its Barrier
                  Price, investors will suffer a loss on their initial investment that is equal to the percentage decline of the Reference Asset with the lowest percentage change from its Initial Price to its Final Price (the &#8220;Least Performing Reference
                  Asset&#8221;) over the term of the Notes. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Price of the Least Performing Reference Asset is less than its Initial Price, and may lose the entire
                  Principal Amount.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8eb35437514643cd9e6995f05b8dcc21">

            <tr>
              <td style="width: 13.3pt; vertical-align: top; font-size: 6pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-size: 6pt;">Any payments on the Notes, including any repayment of principal, are subject to our credit risk.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; font-family: Arial; font-size: 6pt; font-weight: bold;">Key Terms</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2302de3d5fbb4454939b65b3882f8bce">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Issuer:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">The Toronto-Dominion Bank (&#8220;TD&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Reference Assets:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; font-size: 6pt;">The shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF (Bloomberg ticker: IWM, &#8220;IWM&#8221;)</div>
              <div style="text-align: justify; font-size: 6pt;">The shares of the Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1<font style="font-weight: bold;">&#160;</font>(Bloomberg ticker: QQQ, &#8220;QQQ&#8221;)</div>
              <div style="text-align: justify; font-size: 6pt;">The shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust (Bloomberg ticker: SPY, &#8220;SPY&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Principal Amount:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">$1,000 per Note, subject to a minimum investment of $10,000 and integral multiples of $1,000 in excess thereof.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Term:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">Approximately 54 weeks, subject to an automatic call.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Strike Date</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="margin-bottom: 2pt; font-size: 6pt;">October 17, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Pricing Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="margin-bottom: 2pt; font-size: 6pt;">October 20, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Issue Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">October 23, 2025, which is the third DTC settlement day following the Pricing Date. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; herein.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Maturity Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">November 4, 2026, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Call Feature:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">If the Closing Price of <font style="font-weight: bold;">each</font> Reference Asset on any Review Date other than the Final Review Date is greater than or equal to its
                Initial Price, we will automatically call the Notes and, on the applicable Call Payment Date, we will pay you a cash payment equal to the Principal Amount, plus the Contingent Interest Payment otherwise due<font style="font-weight: bold;">&#160;</font>and


                any previously unpaid Contingent Interest Payments with respect to any previous Review Dates pursuant to the Memory Interest Feature. No further amounts will be owed to you under the Notes.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Call Payment Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">If the Notes are subject to an automatic call, the Call Payment Date will be the Contingent Interest Payment Date immediately following the relevant Review Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Review Dates:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">Quarterly, on January 30, 2026, May 1, 2026, July 31, 2026 and October 30, 2026 (the &#8220;Final Review Date&#8221;). Each Review Date is subject to postponement upon the occurrence
                of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Contingent Interest</div>
              <div style="font-size: 6pt;">Payment Feature:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">If the Closing Price of <font style="font-weight: bold;">each</font> Reference Asset on any Review Date is greater than or equal to its Barrier Price, a Contingent
                Interest Payment, plus any previously unpaid Contingent Interest Payments with respect to any previous Review Dates pursuant to the Memory Interest Feature, will be paid to you on the corresponding Contingent Interest Payment Date<font style="font-weight: bold;">. Contingent Interest Payments on the Notes are not guaranteed. You will not receive a Contingent Interest Payment on the corresponding Contingent Interest Payment Date if the Closing Price of any Reference
                  Asset on any Review Date is less than its Barrier Price. </font>Any Contingent Interest Payment due on a Note will be paid to the registered holder of such Note, as determined on the record date, which will be the Business Day preceding
                the relevant Contingent Interest Payment Date. All amounts used in or resulting from any calculation relating to a Contingent Interest Payment will be rounded upward or downward as appropriate, to the nearest tenth of a cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Memory Interest</div>
              <div style="font-size: 6pt;">Feature:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 0.1pt; font-size: 6pt;">If a Contingent Interest Payment is not made on a Contingent Interest Payment Date (other than the Maturity Date) because the Closing Price of any Reference Asset is less
                than its Barrier Price on the related Review Date, such Contingent Interest Payment will be made on a later Contingent Interest Payment Date if the Closing Price of each Reference Asset on any subsequent Review Date is greater than or equal
                to its Barrier Price on the relevant Review Date. For the avoidance of doubt, once a previously unpaid Contingent Interest Payment has been made on a later Contingent Interest Payment Date, it will not be made again on any subsequent
                Contingent Interest Payment Date. If the Closing Price of any Reference Asset is less than its Barrier Price on each of the Review Dates, you will receive no Contingent Interest Payments during the term of, and will not receive a positive
                return on, the Notes.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Contingent Interest</div>
              <div style="font-size: 6pt;">Payment:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 6pt; margin-bottom: 2pt; font-size: 6pt;">$27.125 per $1,000 Principal Amount of the Notes, if payable.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Contingent Interest</div>
              <div style="font-size: 6pt;">Payment Dates:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">With respect to each Review Date, the third Business Day following the related Review Date, with the exception that the final Contingent Interest Payment Date will be the
                Maturity Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Payment at Maturity</div>
              <div style="font-size: 6pt;">(if not called):</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="margin-top: 2pt; font-size: 6pt;">If the Notes are not automatically called, on the Maturity Date, in addition to any Contingent Interest Payment otherwise due, we will pay a cash payment, if anything, per Note equal to:</div>
              <div style="margin-top: 2pt; margin-left: 9pt;"><font style="font-size: 6pt;">&#8226;&#160;&#160;&#160; If the Final Price of <font style="font-weight: bold;">each</font> Reference Asset is <font style="font-weight: bold;">greater than or equal to </font>its
                  Barrier Price: The Principal Amount of $1,000.</font></div>
              <div style="margin-top: 2pt; margin-left: 9pt;"><font style="font-size: 6pt;">&#8226;&#160;&#160;&#160; If <font style="font-weight: bold;">the</font> Final Price of <font style="font-weight: bold;">any </font>Reference Asset is<font style="font-weight: bold;">
                    less than</font> its Barrier Price: The sum of (1) $1,000 plus (2) the product of (i) $1,000 times (ii) the Least Performing Percentage Change.</font></div>
              <div style="margin-top: 2pt; font-size: 6pt; margin-left: 18pt;"><font style="font-weight: bold;">If the Notes are not automatically called and the Final Price of any Reference Asset is less than its Barrier Price, you will suffer a loss on
                  your initial investment that is equal to the percentage change of the Least Performing Reference Asset from its Initial Price to its Final Price (the &#8220;Least Performing Percentage Change&#8221;). Specifically, you will lose 1% of the Principal
                  Amount of the Notes for each 1% that the Final Price of the Least Performing Reference Asset is less than its Initial Price, and may lose your entire Principal Amount. Any payments on the Notes are subject to our credit risk. </font>All
                amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward as appropriate, to the nearest cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Percentage Change:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="font-size: 6pt;">For each Reference Asset, the quotient, expressed as a percentage, of the following formula:</div>
              <div style="text-align: center; margin-right: 188.9pt; font-size: 6pt;"><u>Final Price &#8211; Initial Price</u></div>
              <div style="text-align: center; margin-right: 188.9pt; font-size: 6pt;">Initial Price</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Least Performing</div>
              <div style="font-size: 6pt;">Reference Asset:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 6pt; margin-bottom: 2pt; font-size: 6pt;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Least Performing</div>
              <div style="font-size: 6pt;">Percentage Change:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 6pt; margin-bottom: 2pt; font-size: 6pt;">The Percentage Change of the Least Performing Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Initial Price:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; font-size: 6pt;">With respect to IWM, $243.41</div>
              <div style="text-align: justify; font-size: 6pt;">With respect to QQQ, $603.93</div>
              <div style="text-align: justify; font-size: 6pt;">With respect to SPY, $664.39</div>
              <div style="text-align: justify; font-size: 6pt;">in each case equal to its Closing Price on the Strike Date, as determined by the Calculation Agent, and subject to adjustment as described under &#8220;General Terms of the Notes &#8212; Anti-Dilution
                Adjustments&#8221; in the product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Final Price:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">For each Reference Asset, the Closing Price of such Reference Asset on the Final Review Date, as determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Barrier Price:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; font-size: 6pt;">With respect to IWM, $170.387</div>
              <div style="text-align: justify; font-size: 6pt;">With respect to QQQ, $422.751</div>
              <div style="text-align: justify; font-size: 6pt;">With respect to SPY, $465.073</div>
              <div style="text-align: justify; font-size: 6pt;">in each case equal to 70.00% of its Initial Price, as determined by the Calculation Agent, and subject to adjustment as described under &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221;
                in the product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">89115HYR2/ US89115HYR29</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 2pt; margin-bottom: 2pt; font-family: Arial; font-size: 5.5pt;">The estimated value of your Notes on the Pricing Date was $985.20 per Note, as discussed further under &#8220;Additional Risk Factors &#8212; Risks
        Relating to Estimated Value and Liquidity&#8221; beginning on page P-6 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-22 of this pricing supplement. The estimated value is less than the public offering price of the
        Notes.</div>
      <div style="text-align: justify; margin-top: 2pt; margin-bottom: 2pt; font-family: Arial; font-size: 5.5pt;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada
        Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency or instrumentality.The Notes will not be listed or displayed on any securities exchange or any electronic communications network.</div>
      <div style="text-align: justify; margin-top: 2pt; margin-bottom: 2pt; font-family: Arial; font-size: 5.5pt; font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks. See &#8220;Additional Risk Factors&#8221;
        beginning on page P-3 of this pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-ES-ETF-1 dated February 26, 2025 (the &#8220;product supplement&#8221;) and &#8220;Risk Factors&#8221; on page 1 of the
        prospectus dated February 26, 2025 (the &#8220;prospectus&#8221;). Neither the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes or determined that this pricing supplement, the
        product supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze1b6a26ee346457584ac8a22fbda187d">

          <tr>
            <td style="width: 20.81%; vertical-align: top; border-bottom: #D9D9D9 1px solid;"><br>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; font-size: 6pt; font-weight: bold;">Public Offering Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; font-size: 6pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">12</sup></div>
            </td>
            <td style="width: 29.12%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; font-size: 6pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 20.81%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; color: rgb(0, 0, 0); font-size: 6pt;">Per Note</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$1,000.00</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; font-size: 6pt;"><font style="color: rgb(0, 0, 0);">$</font>10.00</div>
            </td>
            <td style="width: 29.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; font-size: 6pt;"><font style="color: rgb(0, 0, 0);">$</font>990.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20.81%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; color: rgb(0, 0, 0); font-size: 6pt;">Total</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$500,000.00</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$5,000.00</div>
            </td>
            <td style="width: 29.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$495,000.00</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z22e007c2d63c43908fb0dad5136692c2" style="font-family: Arial; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; font-size: 5.5pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; font-size: 5.5pt;">The public offering price for investors purchasing the Notes in fiduciary accounts may have been as low as $990.00 (99.00%) per Note.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z458b1f9d9b8f4a76806714cf6efeb24b" style="font-family: Arial; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; font-size: 5.5pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; font-size: 5.5pt;">TD Securities (USA) LLC (&#8220;TDS&#8221; or the &#8220;Agent&#8221;) will receive a commission of $10.00 per Note sold in this offering. J.P. Morgan Securities LLC, which we refer to as JPMS LLC, and JPMorgan
                  Chase Bank, N.A. will act as placement agents for the Notes and, from the commission to TDS, will receive a placement fee of $10.00 for each Note they sell in this offering to accounts other than fiduciary accounts. TDS and the placement
                  agents will forgo a commission and placement fee for sales to fiduciary accounts. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; in this pricing supplement for additional information.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; font-family: Arial; font-size: 5.5pt;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of
        this pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the
        public offering price you pay for such Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">1</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Additional Terms of Your Notes</div>
      <div style="text-align: justify; margin-bottom: 12pt; font-family: Arial;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement MLN-ES-ETF-1 (the &#8220;product supplement&#8221;), relating to our Senior
        Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any conflict the following hierarchy will
        govern: first, this pricing supplement; second, the product supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the terms described in the product supplement in several important ways. You
          should read this pricing supplement carefully.</font></div>
      <div style="text-align: justify; margin-bottom: 12pt; font-family: Arial;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any
        other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other
        things, the matters set forth under &#8220;Additional Risk Factors&#8221; in this pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with
        conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address
        has changed, by reviewing our filings for the relevant date on the SEC website):</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z7adf700ea9ee463797c447ddb35be90e" style="margin: 0px 0px 10pt; width: 100%; font-family: Arial; font-size: 9pt;">

            <tr style="vertical-align: top;">
              <td style="width: 18pt;"><br>
              </td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left;">&#9726;</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;">Prospectus dated February 26, 2025:</div>
                <div style="text-align: justify;">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
                </div>
              </td>
            </tr>

        </table>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" style="margin: 0px 0px 10pt; width: 100%; font-family: Arial; font-size: 9pt;">

              <tr style="vertical-align: top;">
                <td style="width: 18pt;"><br>
                </td>
                <td style="text-align: right; vertical-align: top; width: 27pt;">
                  <div style="text-align: left;">&#9726;</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify;">
                    <div style="margin-bottom: 6pt;">Product Supplement MLN-ES-ETF-1 dated February 26, 2025:</div>
                  </div>
                  <div style="text-align: justify;">
                    <div>
                      <div><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm</a></div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; font-family: Arial;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The Toronto-Dominion Bank and
        its subsidiaries.</div>
      <div style="text-align: justify; font-family: Arial;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you
        will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">2</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Selected Purchase Considerations</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z08426f0b876247559894d930a31de631">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 13.5pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Limited Return Potential &#8212; </font>The return potential of the Notes is limited to any Contingent Interest Payments you may receive over the term of the Notes and you will not participate in any increase
                in the price of any Reference Asset. If you don&#8217;t receive any Contingent Interest Payments over the term of the Notes, you will not have a positive return on your investment.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="zf6bf34100d5544c380acc1e5d0ab37d4">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 13.5pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;"><font style="font-size: 9pt; font-weight: bold;">Potential For Automatic Call &#8212; </font><font style="font-size: 9pt;">The Notes will be automatically called if the Closing Price of </font><font style="font-size: 9pt; font-weight: bold;">each</font><font style="font-size: 9pt;"> Reference Asset is greater than or equal to its Initial Price on any Review Date other than the Final Review Date and are, therefore, subject to reinvestment risk. If the
                  Notes are automatically called, on the Call Payment Date, you will receive a cash payment per Note equal to the Principal Amount, plus the Contingent Interest Payment otherwise due and any previously unpaid Contingent Interest Payments
                  with respect to any previous Review Dates pursuant to the Memory Interest Feature.</font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="ze87107e911b14eb38bf3f874034964e5">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Contingent Repayment of Principal, with Potential for Full Downside Exposure &#8212; </font>If the Notes are not automatically called and the Final Price of <font style="font-weight: bold;">each </font>Reference


                Asset is greater than or equal to its Barrier Price, in addition to any Contingent Interest Payment otherwise due on the Maturity Date and any previously unpaid Contingent Interest Payments with respect to any previous Review Dates pursuant
                to the Memory Interest Feature, you will receive a cash payment per Note equal to the Principal Amount. If, however, the Notes are not automatically called and the Final Price of <font style="font-weight: bold;">any </font>Reference Asset
                is less than its Barrier Price, you will lose 1% of the Principal Amount of the Notes for each 1% that the Final Price of the Least Performing Reference Asset is less than its Initial Price, and may lose your entire investment in the Notes.
                <font style="font-weight: bold;">You will be exposed to the market risk of each Reference Asset and any decline in the price of one Reference Asset may negatively affect your return on the Notes and will not be offset or mitigated by a
                  lesser decline or any potential increase in the price of any other Reference Asset. Any payments on the Notes, including any repayment of principal, are subject to our credit risk.</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 12pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the terms of the Notes.
        For additional information as to these risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks entailed by an investment in the Notes and the suitability of the Notes in
        light of their particular circumstances.</div>
      <div style="text-align: center; margin-top: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <div style="text-align: left; margin-top: 6pt; font-family: Arial; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if the Notes are not automatically
        called and the Final Price of any Reference Asset is less than its Barrier Price, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Price of the Least Performing Reference Asset is less than its Initial Price,
        and may lose the entire Principal Amount.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">You Will Not Receive the Contingent Interest Payment With Respect to a Review Date on the Corresponding Contingent Interest Payment Date If the Closing Price of
        any Reference Asset on such Review Date Is Less Than its Barrier Price.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">You will not necessarily receive Contingent Interest Payments on the Notes, and thus Contingent Interest Payments should not be viewed as periodic interest payments. You will not
        receive the Contingent Interest Payment with respect to a Review Date on the corresponding Contingent Interest Payment Date if the Closing Price of any Reference Asset on such Review Date is less than its Barrier Price. However, if a Contingent
        Interest Payment is not made on a Contingent Interest Payment Date (other than the Maturity Date) because the Closing Price of any Reference Asset is less than its Barrier Price on the related Review Date, such Contingent Interest Payment will be
        made on a later Contingent Interest Payment Date if the Closing Price of each Reference Asset is greater than or equal to its Barrier Price on the relevant Review Date.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">If the Closing Price of a Reference Asset is less than its Barrier Price on each Review Date over the term of the Notes, you will not receive any Contingent Interest Payments, and
        you will not receive a positive return on, your Notes. Generally, this non-payment of any Contingent Interest Payment will coincide with a greater risk of principal loss on your Notes. Accordingly, if we do not pay any Contingent Interest Payment
        on the Maturity Date, you will incur a loss of principal because the Final Price of the Least Performing Reference Asset will be less than its Barrier Price, and you may lose your entire Principal Amount.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The Potential Positive Return on the Notes Is Limited to the Contingent Interest Payments Paid on the Notes, If Any, Regardless of Any Increase in the Price of
        Any Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The potential positive return on the Notes is limited to any Contingent Interest Payments paid, meaning any positive return on the Notes will be composed solely of the sum of any
        Contingent Interest Payments paid over the term of the Notes. Therefore, if the increase of any Reference Asset exceeds the sum of any Contingent Interest Payments actually paid on the Notes, the return on the Notes will be less than the return on
        a hypothetical direct investment in such Reference Asset or the stocks comprising the Reference Assets (the &#8220;Reference Asset Constituents&#8221;) or in a security directly linked to the positive performance of such Reference Asset or the Reference Asset
        Constituents.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">3</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: Arial; font-weight: bold;">The Contingent Interest Payment Will Reflect, In Part, the Volatility of each Reference Asset and May Not Be Sufficient to Compensate You for the Risk of
        Loss at Maturity.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="color: rgb(0, 0, 0);">Generally, the higher the Reference Assets&#8217; volatility, the more likely it is that the Closing Price or Final Price, as applicable, of each
          Reference Asset could be less than its Initial Price or its Barrier Price on a Review Date or the Final Review Date, as applicable. Volatility means the magnitude and frequency of changes in the prices of the Reference Assets. This greater risk
          will generally be reflected in a higher Contingent Interest Payment for the Notes than the amount payable on our conventional debt securities of a comparable term. However, while the Contingent Interest Payment is set on the Strike Date, the
          Reference Assets&#8217; volatility can change significantly over the term of the Notes, and may increase. The Closing Price or Final Price, as applicable, of any Reference Asset could fall sharply on the Review Dates, including the Final Review Date,
          resulting in few or no Contingent Interest Payments and in a significant or entire loss </font>of principal<font style="color: rgb(0, 0, 0);">.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Your Return May Be Less than the Return on a Conventional Debt Security of Comparable Maturity.</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0); font-family: Arial;">The return that you will receive on your Notes, which could be negative, may be less than the return you could earn on other investments. The Notes do not
        provide for fixed interest payments and you may not receive any Contingent Interest Payments over the term of the Notes. Even if you do receive one or more Contingent Interest Payments and your return on the Notes is positive, your return may be
        less than the return you would earn if you bought a conventional, interest -bearing senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect
        the time value of money.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-weight: bold;">The Notes May Be Automatically Called</font>&#160;<font style="font-weight: bold;">Prior to the Maturity Date</font>&#160;<font style="font-weight: bold;">And


          Are Subject to Reinvestment Risk.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">If your Notes are automatically called, no further payments will be owed to you under the Notes after the applicable Call Payment Date. Therefore, because the Notes could be
        called as early as the first potential Call Payment Date, the holding period could be limited. There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar level of risk
        in the event the Notes are automatically called prior to the Maturity Date. Furthermore, to the extent you are able to reinvest such proceeds in an investment with a comparable return for a similar level of risk, you may incur transaction costs
        such as dealer discounts and hedging costs built into the price of the new notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The Amounts Payable on the Notes, Including the Payment at Maturity, Are Not Linked to the Price of the Least Performing Reference Asset at Any Time Other Than
        on the Applicable Review Dates, Including the Final Review Date.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Any payments on the Notes, including the Payment at Maturity, will be based on the Closing Price of the Least Performing Reference Asset only on the Review Dates (including the
        Final Review Date). Even if the price of the Least Performing Reference Asset increases at any other time but then declines to a Closing Price that is less than its Barrier Price on a Review Date, you will not receive any Contingent Interest
        Payment with respect to such Review Date<font style="font-size: 10pt;">&#160;</font>on the corresponding Contingent Interest Payment Date.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">In addition, any Payment at Maturity will be calculated by reference to the Final Price of the Least Performing Reference Asset, which will be equal to the Closing Price of such
        Reference Asset on the Final Review Date. In calculating the Final Price of the Least Performing Reference Asset, positive performance of such Reference Asset before or after the Final Review Date that would lead to a positive return on the Notes
        will not be taken into account. Therefore, if the Closing Price of the Least Performing Reference Asset is less than its Barrier Price on the Final Review Date, the return on the Notes will be negative, regardless of its Closing Price on any other
        day.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">You Will Have No Rights to Receive Any Shares of Any Reference Asset and You Will Not Be Entitled to Any Dividends or Other Distributions on Any Reference
        Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The Notes are our debt securities. They are not equity instruments, shares of stock, or securities of any other issuer. Investing in the Notes will not make you a holder of shares
        of any Reference Asset. You will not have any voting rights, any rights to receive dividends or other distributions, or any rights against the issuer of any Reference Asset. As a result, the return on your Notes may not reflect the return you would
        realize if you actually owned shares of any Reference Asset and received any dividends paid or other distributions made in connection with them. Your Notes will be paid in cash and you have no right to receive delivery of shares of any Reference
        Asset.</div>
      <div style="text-align: center; margin-top: 6pt; color: rgb(0, 0, 0); font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Asset</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0); font-family: Arial; font-weight: bold;">There Are Market Risks Associated With Each Reference Asset.</div>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: Arial;">The price of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, its sponsor (each, a &#8220;Sponsor&#8221;), the Reference Asset Constituents
        and their issuers (the &#8220;Reference Asset Constituent Issuers&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general
        market factors, such as general stock market volatility and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Sponsors and the Reference Assets for your
        Notes. For additional information, see &#8220;Information Regarding the Reference Assets&#8221; in this pricing supplement and each Sponsor's SEC filings. <font style="font-weight: bold;">We urge you to review financial and other information filed
          periodically by each Sponsor with the SEC.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">4</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: Arial; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on Each Review Date (Including the Final Review Date).</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference Asset. Unlike an
        instrument with a return linked to a basket of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each
        Reference Asset on each Review Date (including the Final Review Date). Poor performance by any Reference Asset over the term of the Notes will negatively affect your return and will not be offset or mitigated by a more favorable performance by any
        other Reference Asset. For instance, you will receive a negative return equal to the Least Performing Percentage Change if the Final Price of any Reference Asset is less than its Barrier Price on its Final Review Date, even if the Percentage Change
        of another Reference Asset is positive or has not declined as much. Accordingly, your investment is subject to the market risk of each Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Because the Notes are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of Not Receiving Any Contingent Interest Payments and
        Losing a Significant Portion or All of Your Initial Investment at Maturity Than if the Notes Were Linked to a Single Reference Asset or Fewer Reference Assets.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The risk that you will not receive any Contingent Interest Payments and lose a significant portion or all of your initial investment in the Notes is greater if you invest in the
        Notes than the risk of investing in substantially similar securities that are linked to the performance of only one Reference Asset or fewer Reference Assets. With more Reference Assets, it is more likely that the Closing Price of any Reference
        Asset will be less than its Barrier Price on any Review Date and that the Final Price of any Reference Asset will be less than its Barrier Price than if the Notes were linked to a single Reference Asset or fewer Reference Assets.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will decline in price to a
        Closing Price that is less than its Barrier Price on any Review Date and a Final Price that is less than its Barrier Price as of the Final Review Date. Although the correlation of the Reference Assets&#8217; performance may change over the term of the
        Notes, the economic terms of the Notes, including the Contingent Interest Payment and Barrier Prices, are determined, in part, based on the correlation of the Reference Assets&#8217; performance calculated using our internal models at the time when the
        terms of the Notes are finalized. All things being equal, a higher Contingent Interest Payment and lower Barrier Prices are generally associated with lower correlation of the Reference Assets. Therefore, if the performance of a pair of Reference
        Assets is not correlated to each other or is negatively correlated, the risk that you will not receive any Contingent Interest Payments and that the Final Price of any Reference Asset will be less than its Barrier Price is even greater despite
        lower Barrier Prices. Therefore, it is more likely that you will not receive any Contingent Interest Payments and that you will lose a significant portion or all of your initial investment at maturity.</div>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Value of a Reference Asset May Not Completely Track Its NAV.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The net asset value (&#8220;NAV&#8221;) of an ETF, including the Reference Assets, may fluctuate with changes in the market value of its Reference Asset Constituents. The market values of
        an ETF may fluctuate in accordance with changes in NAV and supply and demand on the applicable stock exchange(s). Furthermore, the Reference Asset Constituents may be unavailable in the secondary market during periods of market volatility, which
        may make it difficult for market participants to accurately calculate the intraday NAV per share of the applicable Reference Asset and may adversely affect the liquidity and prices of such Reference Asset, perhaps significantly. For any of these
        reasons, the market value of a Reference Asset may differ from its NAV per share and may trade at, above or below its NAV per share.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">We Have No Affiliation With Any Index Sponsor or Sponsor and Will Not Be Responsible for Any Actions Taken by Any Such Entity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">No Index Sponsor or Sponsor is an affiliate of ours and no such entity will be involved in the offering of the Notes in any way. Consequently, we have no control over the
        actions of any Index Sponsor or Sponsor, including any actions of the type that would require the Calculation Agent to adjust any amount payable on the Notes. No Index Sponsor or Sponsor has any obligation of any sort with respect to the Notes.
        Thus, no Index Sponsor or Sponsor has any obligation to take your interests into consideration for any reason, including in taking any actions that might affect the price of the applicable Reference Asset or the Notes. None of our proceeds from the
        issuance of the Notes will be delivered to any Index Sponsor or Sponsor.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Adjustments to a Reference Asset Could Adversely Affect the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Sponsors (as specified under &#8220;Information Regarding the Reference Assets&#8221;) are responsible for calculating and maintaining their applicable Reference Asset. A Sponsor can
        add, delete or substitute the Reference Asset Constituents for its Reference Asset. A Sponsor may make other methodological changes to its Reference Asset that could change the price of such Reference Asset at any time. If one or more of these
        events occurs, the Closing Price of such Reference Asset may be adjusted to reflect such event or events, which could adversely affect the market value of, and return on, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Changes that Affect the Target Index of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        ETF Trust Will Affect the Market Value of, and Return on, the Notes.</div>
      <div style="text-align: justify; font-family: Arial;">The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust is an ETF that seeks to provide investment results that,
        before fees and expenses, correspond generally to the price and yield performance of its Target Index (as specified herein). The policies of the sponsor of its Target Index (an &#8220;Index Sponsor&#8221;) concerning the calculation of its Target Index,
        additions, deletions or substitutions of the components of its Target Index and the manner in which changes affecting those components, such as stock dividends, reorganizations or mergers, may be reflected in its Target Index and, therefore, could
        adversely affect the return on the Notes and the market value of the Notes prior to maturity. The market value of, and return on, the Notes could also be affected if the Index Sponsor changes these policies, for example, by changing the manner in
        which it calculates its Target Index. Some of the risks that relate to a Target Index of an ETF include those discussed in the product supplement, which you should review.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">5</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Performance of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust
        May Not Correlate With That of Its Target Index.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The performance of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust may not exactly
        replicate the performance of its Target Index because the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust will reflect transaction costs and fees that are not
        included in the calculation of its Target Index. It is also possible that the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust may not fully replicate or may in
        certain circumstances diverge significantly from the performance of its Target Index due to the temporary unavailability of certain securities in the secondary market, the performance of any derivative instruments contained in the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust, differences in trading hours between the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust and its Target Index or due to other circumstances.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">There Are Liquidity and Management Risks Associated with an ETF and the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and
        SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust Utilizes a Passive Indexing Investment Approach.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Although shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust are listed for
        trading on a securities exchange and a number of similar products have been traded on various exchanges for varying periods of time, there is no assurance that an active trading market will continue for such shares or that there will be liquidity
        in that trading market. The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust is subject to management risk, which is the risk that its Sponsor&#8217;s investment
        strategy, the implementation of which is subject to a number of constraints, may not produce the intended results. Additionally, the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        ETF Trust is not managed according to traditional methods of &#8220;active&#8221; investment management, which involves the buying and selling of securities based on economic, financial and market analysis and investment judgment. Instead, utilizing a
        &#8220;passive&#8221; or indexing investment approach, it attempts to approximate the investment performance of its Target Index by investing in Reference Asset Constituents that generally replicate its Target Index. Therefore, unless a specific stock is
        removed from its Target Index, the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust generally would not sell a stock because that stock&#8217;s issuer was in financial
        trouble.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Notes are Subject to Risks Associated with Small-Capitalization Companies.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Notes are subject to risks associated with small-capitalization companies because the Reference Asset Constituents of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF are
        considered small-capitalization companies. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore such index may be more volatile than an index in which a
        greater percentage of its constituents are issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments,
        and the stocks of small-capitalization companies may be thinly traded. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel, making
        them more vulnerable to loss of personnel. Small-capitalization companies are often given less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less
        diverse product lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.</div>
      <div style="text-align: center; margin-top: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The Estimated Value of Your Notes Is Less Than the Public Offering Price of Your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The estimated value of your Notes is less than the public offering price of your Notes. The difference between the public offering price of your Notes and the estimated value of
        the Notes reflects costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market forces beyond our
        control, this hedging may result in a profit that is more or less than expected, or a loss.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The estimated value of your Notes is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the Notes
        generally represents a discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other things, our view
        of the funding value of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge
        positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional, fixed-rate debt
        securities were to be used, we would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is expected to increase
        the estimated value of the Notes at any time.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">6</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: Arial; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different from the Pricing Models of Other Financial
        Institutions.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The estimated value of your Notes is based on our internal pricing models, which take into account a number of variables, such as our internal funding rate on the Pricing Date,
        and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing models and the
        methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary market. As a result, the secondary market price of your Notes
        may be materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be incorrect.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, If Any, and Such Secondary Market
        Prices, If Any, Will Likely be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in
        secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many factors that cannot
        be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into account the levels at
        which our debt securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes, secondary market
        prices of your Notes will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market
        transactions, if any, will likely be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;"><font style="color: rgb(0, 0, 0);">If the Price of any Reference </font>Asset<font style="color: rgb(0, 0, 0);"> Changes, the Market Value of Your Notes May
          Not Change in the Same Manner.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Changes in the price of any Reference <font style="color: rgb(0, 0, 0);">Asset may not
          result in a comparable change in </font>the<font style="color: rgb(0, 0, 0);"> market value of your Notes. Even if the Closing Price of each Reference Asset remains greater than or equal to its Barrier Price or increases to greater than its
          Initial Price during the term of the Notes, the market value of your Notes may not increase by the same amount and could decline.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market (if the Agent
        makes a market in the Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of the Notes, as
        discussed further under &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than the public offering
        price. The public offering price includes, and any price quoted to you is likely to exclude, the underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the
        Notes. In addition, any such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or any electronic communications network. The Agent
        or another of our affiliates may make a market for the Notes; however, they are not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide significant liquidity
        or trade at prices advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be substantial.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">If you sell your Notes before an automatic call or the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the price of
        the then-current Least Performing Reference Asset at such time, and as a result, you may suffer substantial losses.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">7</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The Calculation Agent will, among other things, determine the amounts payable on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent
        after the Issue Date without notice to you. The Calculation Agent will exercise its judgment when performing its functions. For example, the Calculation Agent may have to determine whether a market disruption event affecting a Reference Asset has
        occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has materially interfered with our ability or the ability of one of our affiliates to unwind our
        hedge positions. Because this determination by the Calculation Agent may affect the amounts payable on the Notes, the Calculation Agent may have a conflict of interest if it needs to make a determination of this kind. For additional information on
        the Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">You Will Have Limited Anti-Dilution Protection and, in Certain Situations, Your Return on the Notes May be Based on a Substitute Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The Calculation Agent may adjust the Initial Price and Barrier Price for stock splits, reverse stock splits, stock dividends, extraordinary dividends and other events that affect
        the Reference Asset upon the occurrence of certain events affecting the Reference Asset, as described in the product supplement under the section &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221;. The Calculation Agent is not required to
        make an adjustment for every event that may affect the Reference Asset. Furthermore, in certain situations, such as when the Reference Asset undergoes a Reorganization Event or the Reference Asset is delisted, the Reference Asset may be replaced by
        distribution property or a substitute equity security, as discussed more fully in the product supplement under &#8220;General Terms of the Notes&#8221;. Notwithstanding the Calculation Agent&#8217;s ability to make adjustments to the terms of the Notes and the
        Reference Asset, those events or other actions affecting the Reference Asset, Reference Asset Constituent Issuer, Sponsor or a third party may nevertheless adversely affect the price of the Reference Asset and, therefore, adversely affect the
        market value of, and return on, your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Any Review Date (including the Final Review Date) and the Related Payment Dates are Subject to Market Disruption Events and Postponement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Each Review Date (including the Final Review Date) and the related payment dates (including the Maturity Date) are subject to postponement as described herein and in the product
        supplement due to the occurrence of one or more market disruption events, which, among other events, may occur if the Calculation Agent determines that an event materially interferes with our ability or any of our affiliates to maintain or unwind
        all or a material portion of a hedge with respect to the Notes that we or our affiliates have effected or may effect or to effect trading in the Reference Assets generally. For a description of what constitutes a market disruption event as well as
        the consequences of that market disruption event, see &#8220;General Terms of the Notes&#8212;Market Disruption Events&#8221; in the product supplement. A market disruption event for a particular Reference Asset will not constitute a market disruption event for any
        other Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Trading and Business Activities by TD or its Affiliates May Adversely Affect the Market Value of, and Any Amounts Payable on, the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We, the Agent and/or one or more of our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments with
        returns linked or related to changes in the prices of one or more Reference Assets or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It
        is possible that we and/or one or more of our affiliates could receive substantial returns from these hedging activities while the market value of, and return on, the Notes declines. We and/or one or more of our affiliates may also issue or
        underwrite other securities or financial or derivative instruments with returns linked or related to changes in the performance of a Reference Asset or one or more Reference Asset Constituents.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and/or our affiliates will have in our or their proprietary
        accounts, in facilitating transactions, including options and other derivatives transactions, for our and/or their customers&#8217; accounts and in accounts under our and/or their management. These trading activities could be adverse to the interests of
        the holders of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We, the Agent and/or another of our affiliates may, at present or in the future, engage in business with one or more Reference Asset Constituent Issuers, such as making loans or
        providing investment banking and merger and acquisition advisory services. These business activities may present a conflict between our and/or one or more of our affiliates&#8217; (including the Agent&#8217;s) obligations and your interests as a holder of the
        Notes. Moreover, we, the Agent and/or another of our affiliates may have published, and in the future expect to publish, research reports with respect to one or more Reference Assets or one or more Reference Asset Constituent Issuers. This research
        is modified from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Notes. Any of these activities by us, the Agent and/or another of our affiliates may affect the
        prices of such Reference Assets and, therefore, the market value of, and return on, the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">8</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject to TD&#8217;s credit
        risk. The Notes are TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s
        creditworthiness. Any decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its financial
        obligations as they become due, investors may not receive any amounts due under the terms of the Notes.</div>
      <div style="text-align: center; margin-top: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Significant aspects of the U.S. tax treatment of the Notes are uncertain. You should consult your tax advisor about your tax situation and should read carefully the sections
        entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement. You should consult your tax advisor as to the tax consequences of your investment in the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The U.S. federal income tax treatment of the Contingent Interest Payments is unclear with respect to non-U.S. holders. <font style="font-weight: bold;">Accordingly, we will treat
          any Contingent Interest Payments on the Notes as subject to a 30% U.S. withholding tax. To the extent we have withholding responsibilities with respect to a Note, we intend to withhold such tax on any Contingent Interest Payment and we anticipate
          that other withholding agents would do the same. You are urged to consult your tax advisors regarding the application of the withholding tax to your Notes and the availability of any reduction in tax pursuant to an income tax treaty. No assurance
          can be given that you will be able to successfully claim a reduction in tax pursuant to an applicable income tax treaty. We will not pay any additional amounts in respect of any such withholding.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian
        Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Additional Terms&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for
        Canadian federal income tax purposes or if you acquire the Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due
        under the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">9</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb220578d5e904592be7a6adc22b4ba6d">

          <tr>
            <td style="width: 50%; vertical-align: middle;"><br>
            </td>
            <td style="width: 50%; vertical-align: middle;">
              <div style="text-align: right; text-indent: -121.5pt; margin-left: 121.5pt; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Autocallable Contingent Interest Barrier Notes with Memory Interest</div>
              <div style="text-align: right; text-indent: -121.5pt; margin-left: 121.5pt; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Linked to the Least Performing of the Shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell</div>
              <div style="text-align: right; text-indent: -121.5pt; margin-left: 121.5pt; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">2000 ETF, the Shares of the Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup> and the Shares of</div>
              <div style="text-align: right; text-indent: -121.7pt; margin-left: 121.7pt; margin-bottom: 6pt; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust Due November 4, 2026</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8859404bbe3a42b9b24f5cbae04f4112">

          <tr>
            <td style="background-color: #000000; vertical-align: top; width: 100%;"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Additional Terms</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The information in this &#8220;Additional Terms&#8221; section supplements, and to the extent inconsistent supersedes, the information set forth in the product supplement and the
        prospectus.</div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1abc7645fd6a4d7bba0ac00b25351f6d">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Type of Note:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Autocallable Contingent Interest Barrier Notes with Memory Interest</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TDS</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Currency:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">U.S. Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Monitoring Period:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to each Reference Asset, for purposes of the determination of the Final Price, the Calculation Agent will observe the Closing Price of such Reference Asset on the Final Review
                Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Change in Law Event:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Not applicable, notwithstanding anything to the contrary in the product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Canadian Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221;, which
                applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as defined in the
                prospectus).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Business Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law to close in New
                York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Calculation Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Canadian Bail-in:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes are not bail-inable debt securities (as described in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">10</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Hypothetical Returns</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The examples set out below are included for illustration purposes only and are hypothetical examples only; amounts below may have been rounded for ease of analysis. The
        hypothetical Initial Price, Closing Price, Final Price and<font style="font-weight: bold;">&#160;</font>Percentage Changes of the Reference Assets used to illustrate the calculation of whether a Contingent Interest Payment is payable on a Contingent
        Interest Payment Date and the Payment at Maturity are not estimates or forecasts of the actual Initial Price, the Closing Price or the Final Price of any Reference Asset on any Trading Day prior to the Maturity Date. All examples assume, for each
        Reference Asset, an Initial Price of $100.00, a Barrier Price of $70.00 (70.00% of its Initial Price), a Contingent Interest Payment of $27.125 per Note, that the Notes may be subject to an automatic call on any Review Date other than the Final
        Review Date, that a holder purchased Notes with a Principal Amount of $1,000 and that no market disruption event occurs on any Review Date, including the Final Review Date. The actual terms of the Notes are indicated on the cover hereof.</div>
      <div style="font-family: Arial; text-align: justify;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb3bb2b6812074a34bcd4374ee272692e">

          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 1 &#8212;</div>
            </td>
            <td style="width: 90%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes Are Automatically Called on the First Potential Call Payment Date.</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z1d49b81f841a4849b90d9cbbdd456994" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Prices</div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">First</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">Reference Asset A: $</font>120.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal
                    to</font><font style="color: rgb(0, 0, 0);"> its Initial Price and Barrier Price)</font></div>
                <div style="margin: 2pt 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset B: $</font>115.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal
                    to</font><font style="color: rgb(0, 0, 0);"> its Initial Price and Barrier Price)</font></div>
                <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset C: $</font>110.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial Price and Barrier Price)</font></div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
                <div style="text-indent: 0.9pt; color: rgb(0, 0, 0);">$1,000 (Principal Amount)</div>
                <div style="color: rgb(0, 0, 0);"><u>+ $27.125</u> (Contingent Interest Payment)</div>
                <div style="color: rgb(0, 0, 0);">$1,027.125 (Total Payment upon Automatic Call)</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td nowrap="nowrap" rowspan="1" style="width: 49%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
              <td nowrap="nowrap" rowspan="1" style="width: 33%; vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;"><br>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
                <div style="text-align: right; color: rgb(0, 0, 0);">Total Payment:</div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$1,027.125 (2.7125% total return)</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div style="text-align: justify; margin-top: 3pt; font-family: Arial;">Because the <font style="color: rgb(0, 0, 0);">Closing Price </font>of each Reference Asset on the first Review Date is greater than or equal to its Initial Price (and therefore
        also greater than its Barrier Price), the Notes will be automatically called and, on the Call Payment Date, we will pay you a cash payment equal to $<font style="color: rgb(0, 0, 0);">1,027.125 </font>per Note, reflecting the Principal Amount plus
        the applicable Contingent Interest Payment, for a return of <font style="color: rgb(0, 0, 0);">2.7125% </font>per Note. No further amounts will be owed under the Notes.</div>
      <div style="text-align: justify; margin-left: 4.5pt; margin-top: 3pt; font-family: Arial;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd0c9ce3de947455a829c671985e9eb1d">

          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 2 &#8212;</div>
            </td>
            <td style="width: 90%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-weight: bold;">The Notes Are Automatically Called on the</font> <font style="font-weight: bold;">Third Potential Call Payment Date.</font></div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z673c02e67d39434fb792d0fea3f88831" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Prices</div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">First</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td style="width: 49%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: $75.00 (<font style="font-weight: bold;">less than</font> its Initial Price; <font style="font-weight: bold;">greater than or equal to</font> its
                  Barrier Price)</div>
                <div style="margin: 2pt 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset B: $115.00 (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);">
                    its Initial Price</font> <font style="color: rgb(0, 0, 0);">and Barrier Price)</font></div>
                <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset C: $110.00 (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial
                    Price</font> <font style="color: rgb(0, 0, 0);">and Barrier Price)</font></div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$27.125 (Contingent Interest Payment)</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 49%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
              <td nowrap="nowrap" rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Second</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td style="width: 49%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: $55.00 (<font style="font-weight: bold;">less than</font> its Initial Price and Barrier Price)</div>
                <div style="margin: 2pt 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset B: $120.00 (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);">
                    its Initial Price</font> <font style="color: rgb(0, 0, 0);">and Barrier Price)</font></div>
                <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset C: $110.00 (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial
                    Price</font> <font style="color: rgb(0, 0, 0);">and Barrier Price)</font></div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$0.00</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 49%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
              <td nowrap="nowrap" rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Third</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">Reference Asset A: $</font>130.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal
                    to</font><font style="color: rgb(0, 0, 0);"> its Initial Price and Barrier Price)</font></div>
                <div style="margin: 2pt 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset B: $</font>140.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal
                    to</font><font style="color: rgb(0, 0, 0);"> its</font> <font style="color: rgb(0, 0, 0);">Initial Price and Barrier Price)</font></div>
                <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset C: $</font>120.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its</font> <font style="color: rgb(0, 0, 0);">Initial Price and Barrier Price)</font></div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td style="width: 33%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0);">$1,000.00&#160; (Principal Amount)</div>
                <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);"><u>+ $</u></font><u>54.25</u><font style="color: rgb(0, 0, 0);"> (Contingent Interest Payment and previously unpaid Contingent Interest Payment(s) in respect of the prior
                    Review Date(s))</font></div>
                <div><font style="color: rgb(0, 0, 0);">$1,054.25 (</font>Total<font style="color: rgb(0, 0, 0);"> Payment upon Automatic Call)</font></div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td nowrap="nowrap" rowspan="1" style="width: 49%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;"><br>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
                <div style="text-align: right; color: rgb(0, 0, 0);">Total Payment:</div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$1,081.375 (8.1375% total return)</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Because the Closing Price of at least one Reference Asset on the first Review Date is less than its Initial Price and the Closing Price of each Reference is greater than or equal
        to its Barrier Price, we will pay you the Contingent Interest Payment with respect to such Review Date on the corresponding Contingent Interest Payment Date. Because the <font style="color: rgb(0, 0, 0);">Closing Price </font>of at least one
        Reference Asset on <font style="color: rgb(0, 0, 0);">the second</font></div>
      <div style="font-family: Arial; text-align: justify;"><font style="color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">11</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-family: Arial; text-align: justify;">
        <div>Review Date is less than its Barrier Price, we will not pay a Contingent Interest Payment with respect to such Review Date on the corresponding Contingent Interest Payment Date.
          Because the Closing Price of each Reference Asset is greater than or equal to its Initial Price (and therefore also greater than its Barrier Price) on the third Review Date, the Notes will be automatically called and, on the Call Payment Date, we
          will pay you a cash payment equal to $1,054.25 per Note, reflecting the Principal Amount plus the Contingent Interest Payment with respect to such Review Date&#160;and the previously unpaid Contingent Interest Payment(s) with respect to the prior
          Review Date(s). When added to the Contingent Interest Payment of $27.125 paid in respect of the first Contingent Interest Payment Date, TD will have paid you a total of $1,081.375 per Note, for a return of 8.1375% per Note.</div>
        <div>&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd30359e90936424dbad60f46aae22249">

          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 3 &#8212;</div>
            </td>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin: 0px 0px 3pt; font-weight: bold; text-align: justify;">The Closing Price of at Least One Reference Asset is Less Than its Barrier Price on each Review Date Prior to the Final Review Date, the Notes Are Not Automatically
                Called and the Final Price of each Reference Asset is Greater Than its Barrier Price.</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z8af7330d1ba24d23b034bc90334e1f59" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Prices</div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
                <div style="margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">First through </font>Third</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td style="width: 49%; vertical-align: top;">
                <div style="margin: 3pt 0px 2pt; color: #000000; text-align: justify;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Initial Price and Barrier Price)</div>
                <div style="margin: 0px 0px 2pt; color: #000000; text-align: justify;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Initial Price; <font style="font-weight: bold;">greater than or equal to</font>
                  its Barrier Price)</div>
                <div style="text-align: justify; color: rgb(0, 0, 0);">Reference Asset C: Various (all <font style="font-weight: bold;">less than</font> its Initial Price; <font style="font-weight: bold;">greater than or equal to</font> its Barrier
                  Price)</div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$0.00</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 49%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
              <td nowrap="nowrap" rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
                <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Final Review Date</div>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: $75.00 (<font style="font-weight: bold;">greater than or equal to</font> its Barrier Price)</div>
                <div style="margin: 2pt 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset B: $</font>110.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal
                    to</font><font style="color: rgb(0, 0, 0);"> its Barrier Price)</font></div>
                <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset C: $</font>120.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Barrier Price)</font></div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td style="width: 33%; vertical-align: bottom;">
                <div style="text-indent: 0.9pt; color: rgb(0, 0, 0);">$1,000 (Principal Amount)</div>
                <div style="color: rgb(0, 0, 0);"><u>+ $108.50</u> (Contingent Interest Payment and previously unpaid Contingent Interest Payment(s) in respect of the prior Review Date(s))</div>
                <div><font style="color: rgb(0, 0, 0);">$1,108.50</font>&#160;<font style="color: rgb(0, 0, 0);">(Total Payment on Maturity Date)</font></div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td nowrap="nowrap" rowspan="1" style="width: 49%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 15%; vertical-align: bottom;"><br>
              </td>
              <td style="width: 1%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
                <div style="text-align: right; color: rgb(0, 0, 0);">Total Payment:</div>
              </td>
              <td style="width: 2%; vertical-align: top;"><br>
              </td>
              <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
                <div><font style="color: rgb(0, 0, 0);">&#160;$1,108.50</font>&#160;<font style="color: rgb(0, 0, 0);">(10.85% total return)</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div> </div>
      <div style="text-align: justify; margin-top: 3pt; font-family: Arial;">
        <div style="margin: 6pt 0px; text-align: left;">Because the Closing Price of at least one Reference Asset on each Review Date prior to the Final Review Date is less than its Initial Price and Barrier Price, we
          will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be automatically called. Because the Final Price of each Reference Asset is greater than or equal to its Barrier
          Price on the Final Review Date, on the Maturity Date we will pay you a cash payment equal to $1,108.50 per Note, reflecting the Principal Amount plus the applicable Contingent Interest Payment with respect to the Final Review Date and the
          previously unpaid Contingent Interest Payment(s) with respect to the prior Review Date(s). In this scenario, TD will have paid you a total of $1,108.50 per Note, for a return of 10.85% per Note.</div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6513efadee26459994210039c985f8e9">

          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 4 &#8212;</div>
            </td>
            <td style="width: 90%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Closing Price of at Least One Reference Asset is Less Than its Barrier Price on each Review Date Prior to the Final Review Date, the Notes Are Not Automatically
                Called and the Final Price of the Least Performing Reference Asset is Less Than its Barrier Price.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9205437392944753979a5c635470d570">

          <tr>
            <td nowrap="nowrap" style="width: 15%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
            </td>
            <td nowrap="nowrap" colspan="1" style="width: 1%; vertical-align: bottom;"><br>
            </td>
            <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Prices</div>
            </td>
            <td style="width: 2%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">First through Third</div>
            </td>
            <td nowrap="nowrap" colspan="1" style="width: 1%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" style="width: 49%; vertical-align: middle;">
              <div style="text-align: justify; margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Initial Price and Barrier Price)</div>
              <div style="margin: 2pt 0px; color: #000000; text-align: justify;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Initial Price)</div>
              <div style="text-align: justify; color: rgb(0, 0, 0);">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Initial Price)</div>
            </td>
            <td style="width: 2%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" style="width: 33%; vertical-align: top;">
              <div style="margin-top: 6pt; color: rgb(0, 0, 0);">&#160;$0.00</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" rowspan="1" style="width: 49%; vertical-align: middle;">&#160;</td>
            <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Final Review Date</div>
            </td>
            <td nowrap="nowrap" colspan="1" style="width: 1%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" style="width: 49%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">Reference Asset A: $</font>40.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">less than</font><font style="color: rgb(0, 0, 0);"> its Barrier Price)</font></div>
              <div style="margin: 2pt 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset B: $</font>115.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Barrier Price)</font></div>
              <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Reference Asset C: $</font>110.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Barrier Price)</font></div>
            </td>
            <td style="width: 2%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">= $1,000 + ($1,000 &#215; Least Performing Percentage Change)</div>
              <div style="color: rgb(0, 0, 0);">= $1,000 + ($1,000 &#215; -60.00%)</div>
              <div style="color: rgb(0, 0, 0);">= $400.00 (Total Payment on Maturity Date)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" rowspan="1" style="width: 49%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" rowspan="1" style="width: 33%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 15%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" colspan="1" style="width: 1%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">Total Payment:</div>
            </td>
            <td style="width: 2%; vertical-align: top;"><br>
            </td>
            <td nowrap="nowrap" style="width: 33%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">$400.00 (60.00% loss)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="color: rgb(0, 0, 0);">Because the Closing Price </font>of at least one Reference Asset on <font style="color: rgb(0, 0, 0);">each Review Date prior to the Final
          Review Date is less than its Initial Price and Barrier Price, we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be automatically called. Because the Final Price of
          the Least Performing Reference Asset is less than its Barrier Price on the Final Review Date, on the Maturity Date we will pay you a cash payment equal to the Principal Amount plus the product of the Principal Amount and the Least Performing
          Percentage Change, for a total of $400.00 per Note, a loss of 60.00% per Note.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">12</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; font-family: Arial;">The following table illustrates the hypothetical payments per Note that may be realized at maturity for a range of hypothetical Final Prices of the Least Performing Reference
        Asset, based on the hypothetical terms set forth above. The table assumes that the Notes have not been automatically called and does not reflect any Contingent Interest Payment that may be payable prior to the Maturity Date<font style="font-size: 12pt;">&#160;</font>or any previously unpaid Contingent Interest Payments otherwise due on the Maturity Date pursuant to the Memory Interest Feature. The hypothetical returns set forth below are for illustrative purposes only and may not be the actual
        returns applicable to a purchaser of the Notes. The numbers appearing in the following table may have been rounded for ease of analysis.</div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 80%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="z71619ba1f1914312b6a19b557cbc5071">

          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Hypothetical Final</div>
              <div style="text-align: center; font-weight: bold;">Price of Least</div>
              <div style="text-align: center; font-weight: bold;">Performing</div>
              <div style="text-align: center; margin-bottom: 3pt; font-weight: bold;">Reference Asset</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Hypothetical Least</div>
              <div style="text-align: center; font-weight: bold;">Performing</div>
              <div style="text-align: center; margin-bottom: 3pt; font-weight: bold;">Percentage Change</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment at</div>
              <div style="text-align: center; font-weight: bold;">Maturity<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Return on the</div>
              <div style="text-align: center; font-weight: bold;">Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$140.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">40.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,027.125</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$130.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">30.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,027.125</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$120.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">20.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,027.125</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$110.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">10.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,027.125</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$<font style="font-weight: bold;">100.00</font></div>
            </td>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">0.00%</div>
            </td>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">$1,027.125</div>
            </td>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-right: 1px solid; border-top: 1px solid #000000; vertical-align: top; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$90.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-10.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$1,027.125</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$80.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-20.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$1,027.125</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$<font style="font-weight: bold;">70.00</font></div>
            </td>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">-30.00%</div>
            </td>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">$1,027.125</div>
            </td>
            <td style="background-color: #EAF1DD; border-left: 1px solid #000000; border-right: 1px solid; border-top: 1px solid #000000; vertical-align: top; width: 20%;">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">2.7125%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$60.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-40.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$600.000</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-40.0000%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$50.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-50.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$500.000</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-50.0000%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$40.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-60.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$400.000</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-60.0000%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$30.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-70.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$300.000</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-70.0000%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$20.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-80.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$200.000</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-80.0000%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$10.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-90.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$100.000</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-90.0000%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$0.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-100.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$0.000</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">0.0000%</div>
            </td>
          </tr>
          <tr>
            <td colspan="4" rowspan="1" style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-top: 3pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160; </font>Does not include any previously unpaid Contingent Interest Payments otherwise due pursuant to the Memory
                Interest Feature.</div>
              <div style="text-align: justify; margin-top: 3pt; text-indent: -18pt; margin-left: 18pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160; </font>This column reflects the return received only in respect of the
                Payment at Maturity. In addition to this payment, if the Closing Price of each Reference Asset was greater than or equal to its Barrier Price (but below its Initial Price) on one or more of the preceding Review Dates, investors would have
                previously received the applicable Contingent Interest Payment(s) on the corresponding Contingent Interest Payment Date(s).</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">13</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Information Regarding the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Each Reference Asset is registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Companies with securities registered under the Exchange Act are
        required to file periodically certain financial and other information specified by the SEC. Information provided to or filed with the SEC can be inspected and copied at the public reference facilities maintained by the SEC or through the SEC&#8217;s
        website at www.sec.gov. In addition, information regarding a Reference Asset may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, method of calculation, and changes in any Reference
        Asset Constituents, have been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset. The information reflects the policies
        of, and is subject to change by, the Sponsors. The Sponsors, which own the copyright and all other rights to the Reference Assets, have no obligation to continue to publish, and may discontinue publication of, the applicable Reference Asset. None
        of the websites referenced in the Reference Asset descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference. We have not independently verified
        the accuracy or completeness of reports filed by a Sponsor with the SEC, information published by it on its website or in any other format, information about it obtained from any other source or the information provided below.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing Prices of each
        Reference Asset for the periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;). The Closing Prices may be
        adjusted by Bloomberg for corporate actions such as stock splits, public offerings, mergers and acquisitions, spin-offs, delistings and bankruptcy.</div>
      <div style="text-align: justify; font-family: Arial;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset should not be taken as an indication
        of its future performance, and no assurance can be given as to the Closing Price or Final Price of any Reference Asset on any Review Date. We cannot give you any assurance that the performance of the Reference Assets will result in a positive
        return on your initial investment.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">14</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="text-align: justify; font-weight: bold;">iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We have derived all information contained herein regarding the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF (the &#8220;IWM Fund&#8221;) and the Target Index, as defined below, from publicly
        available information. Such information reflects the policies of, and is subject to changes by, the IWM Fund&#8217;s Sponsor, BlackRock Fund Advisors (&#8220;BFA&#8221; or the &#8220;Sponsor&#8221;) and the Index Sponsor of the Target Index, as defined below.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The IWM Fund is one of the separate investment portfolios that constitute the iShares Trust (&#8220;iShares&#8221;). The IWM Fund seeks to provide investment results that correspond generally
        to the price and yield performance, before fees and expenses, of the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;Target Index&#8221;). The Target Index seeks to measure the performance of the small-capitalization segment of the U.S. equity market. The Target
        Index is a subset of the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, which measures the performance of the largest 3,000 U.S. companies, and the Target Index is composed of the smallest 2,000 companies included in the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index. The Target
        Index is calculated, maintained and published by, FTSE Russell (the &#8220;Index Sponsor&#8221;). The Index Sponsor is under no obligation to continue to publish, and may discontinue or suspend the publication of, the Target Index at any time.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">BFA uses a representative sampling strategy to manage the IWM Fund. &#8220;Representative sampling&#8221; is an indexing strategy that involves investing in a representative sample of the
        securities included in the Target Index that the Sponsor determines to collectively have an investment profile similar to that of the Target Index. The securities selected are intended to have, in the aggregate, investment characteristics (based on
        market capitalization and industry weightings), fundamental characteristics (such as return variability and yield) and liquidity measures similar to those of the Target Index. The IWM Fund may or may not hold all of the securities that are included
        in the Target Index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The IWM Fund generally invests at least 80% of its assets in securities of the Target Index and in depositary receipts representing securities of the Target Index. The IWM Fund
        may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, including shares of money market funds advised by BFA or its affiliates, as well as in securities not included in the Target Index,
        but which BFA believes will help track the Target Index. The IWM Fund will concentrate its investments (i.e., hold 25% or more of its total assets) in the stocks of a particular industry or group of industries to approximately the same extent that
        the Target Index is concentrated.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Select information regarding the IWM Fund&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the IWM Fund&#8217;s website.
        Expenses of the IWM Fund reduce the net asset value of the assets held by the IWM Fund and, therefore, reduce the value of the shares of the IWM Fund.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Shares of the IWM Fund are listed on the NYSE Arca under the ticker symbol &#8220;IWM&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information from outside sources including, but not limited to the prospectus related to the IWM Fund and any other website referenced in this section, is not incorporated by
        reference in, and should not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to the IWM Fund or
        the Target Index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information filed by iShares with the SEC, including the prospectus for the IWM Fund, can be found by reference to its SEC file numbers: 333-92935 and 811-09729 or its CIK Code:
        0001100663.</div>
      <div><br>
      </div>
      <div style="text-align: left; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The graph below illustrates the performance of IWM from October 17, 2015 through October 17, 2025. The dotted line represents its Barrier Price of $170.387, which is equal to
        70.00% of its Initial Price.</div>
      <div style="text-align: center; text-indent: 4.5pt; font-family: Arial; font-size: 10pt; font-weight: bold;">iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF (IWM)</div>
      <div style="text-align: center;"><img src="image00004.jpg"></div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">15</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold;">Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We have derived all information contained herein regarding the Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 (the &#8220;QQQ Trust&#8221;) and the Target Index, as defined below, from publicly
        available information. Such information reflects the policies of, and is subject to changes by, the sponsor of the QQQ Trust, Invesco Capital Management LLC (the &#8220;Sponsor&#8221;), the trustee of the QQQ Trust, The Bank of New York Mellon (the &#8220;trustee&#8221;),
        and the Index Sponsor of the Target Index, as defined below.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The QQQ Trust is a unit investment trust that issues securities called &#8220;Trust Units&#8221; as &#8220;Units&#8221; of the QQQ Trust, each of which represents a fractional undivided ownership
        interest in the QQQ Trust. The QQQ Trust holds all the component securities of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (the &#8220;Target Index&#8221;), and is rebalanced quarterly and reconstituted annually. The Target Index includes 100 of the largest domestic and
        international nonfinancial companies listed on the Nasdaq Stock Market based on market capitalization. The Target Index reflects companies across major industry groups including computer hardware and software, telecommunications, retail/wholesale
        trade and biotechnology. It does not contain securities of financial companies including investment companies. The Target Index is calculated, maintained and published by, Nasdaq, Inc. (the &#8220;Index Sponsor&#8221;). The Index Sponsor is under no obligation
        to continue to publish, and may discontinue or suspend the publication of, the Target Index at any time.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The QQQ Trust is not actively managed. The QQQ Trust holds a portfolio of securities consisting of substantially all of the component common stocks, in substantially the same
        weighting, which comprise the Target Index. The trustee on a nondiscretionary basis adjusts the composition of the QQQ Trust to conform to changes in the composition and/or weighting of securities in the Target Index. Although the QQQ Trust may
        fail to own certain securities included in the Target Index at any particular time, the QQQ Trust generally will be substantially invested in the securities included in the Target Index. The QQQ Trust may or may not hold all of the securities that
        are included in the Target Index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Select information regarding the QQQ Trust&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the QQQ Trust&#8217;s website.
        Expenses of the QQQ Trust reduce the net asset value of the assets held by the QQQ Trust and, therefore, reduce the value of the shares of the QQQ Trust.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Shares of the QQQ Trust are listed on the Nasdaq Stock Market under the ticker symbol &#8220;QQQ&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information from outside sources including, but not limited to the prospectus related to the QQQ Trust and any other website referenced in this section, is not incorporated by
        reference in, and should not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to the QQQ Trust or
        the Target Index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information filed by the QQQ Trust with the SEC, including the prospectus for the QQQ Trust, can be found by reference to its SEC file numbers: 333-61001 and 811-08947 or its CIK
        Code: 0001067839.</div>
      <div><br>
      </div>
      <div style="text-align: left; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The graph below illustrates the performance of QQQ from October 17, 2015 through October 17, 2025. The dotted line represents its Barrier Price of $422.751, which is equal to
        70.00% of its Initial Price.</div>
      <div style="text-align: center; margin-top: 6pt; font-family: Arial; font-size: 10pt; font-weight: bold;">Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 (QQQ)</div>
      <div style="text-align: center;"><img src="image00005.jpg"></div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">16</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We have derived all information contained herein regarding the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust (the &#8220;SPY Trust&#8221;) and the Target Index, as defined below, from
        publicly available information. Such information reflects the policies of, and is subject to changes by, the sponsor of the SPY Trust, PDR Services LLC (the &#8220;Sponsor&#8221;), the trustee of the SPY Trust, State Street Global Advisors Trust Company (the
        &#8220;trustee&#8221;) or its parent company, State Street Bank and Trust Company, and the Index Sponsor of the Target Index, as defined below.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The SPY Trust is a unit investment trust that issues securities called &#8220;Units&#8221; of the SPY Trust, each of which represents a fractional undivided ownership interest in the SPY
        Trust. The SPY Trust seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;Target Index&#8221;). The Target Index is designed to measure the
        performance of 500 large-capitalization companies in the U.S. equity market. The Target Index is calculated, maintained and published by, S&amp;P Dow Jones Indices LLC (the &#8220;Index Sponsor&#8221;). The Index Sponsor is under no obligation to continue to
        publish, and may discontinue or suspend the publication of, the Target Index at any time.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The SPY Trust is not actively managed. The SPY Trust holds a portfolio of securities consisting of substantially all of the component common stocks, in substantially the same
        weighting, which comprise the Target Index. The trustee on a nondiscretionary basis adjusts the composition of the SPY Trust to conform to changes in the composition and/or weighting of securities in the Target Index. Although the SPY Trust may
        fail to own certain securities included in the Target Index at any particular time, the SPY Trust generally will be substantially invested in the securities included in the Target Index. The SPY Trust may or may not hold all of the securities that
        are included in the Target Index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Select information regarding the SPY Trust&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the SPY Trust&#8217;s website.
        Expenses of the SPY Trust reduce the net asset value of the assets held by the SPY Trust and, therefore, reduce the value of the shares of the SPY Trust.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Shares of the SPY Trust are listed on the NYSE Arca under the ticker symbol &#8220;SPY&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information from outside sources including, but not limited to the prospectus related to the SPY Trust and any other website referenced in this section, is not incorporated by
        reference in, and should not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to the SPY Trust or
        the Target Index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information filed by the SPY Trust with the SEC, including the prospectus for the SPY Trust, can be found by reference to its SEC file numbers: 033-46080 and 811-06125 or its CIK
        Code: 0000884394.</div>
      <div><br>
      </div>
      <div style="text-align: left; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The graph below illustrates the performance of SPY from October 17, 2015 through October 17, 2025. The dotted line represents its Barrier Price of $465.073, which is equal to
        70.00% of its Initial Price.</div>
      <div style="text-align: center; text-indent: 4.5pt; font-family: Arial; font-size: 10pt; font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust (SPY)</div>
      <div style="text-align: center;"><img src="image00006.jpg"></div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">17</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative authority directly
        discusses how the Notes should be treated for U.S. federal income tax purposes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the
        product supplement and discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of
        the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S.
        laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.
        Except as discussed under the heading &#8220;Non-U.S. Holders&#8221;, this discussion is applicable only to a U.S. holder that acquires Notes upon initial issuance and holds its Notes as a capital asset for U.S. federal income tax purposes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">U.S. Tax Treatment.</font> Pursuant to the terms of the Notes, TD and you agree, in the absence of a statutory or regulatory change or an
        administrative determination or judicial ruling to the contrary, to characterize your Notes as prepaid derivative contracts with respect to the Reference Assets. Pursuant to this treatment, any Contingent Interest Payments paid on the Notes
        (including any Contingent Interest Payments paid on or with respect to the Maturity Date) would be treated as ordinary income includable in income by you in accordance with your regular method of accounting for U.S. federal income tax purposes.
        Holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations. If your Notes are so treated, upon the taxable disposition (including cash settlement) of a Note, you generally
        should recognize gain or loss in an amount equal to the difference between the amount realized on such taxable disposition (adjusted for accrued and unpaid Contingent Interest Payments treated as ordinary income) and your tax basis in the Note.
        Your tax basis in a Note generally should equal your cost for the Note. Subject to the &#8220;constructive ownership&#8221; rules of Section 1260 of the Code, discussed below, such gain or loss should generally be long-term capital gain or loss if you have
        held your Notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less). The deductibility of capital losses is subject to limitations. Although uncertain, it is possible that
        proceeds received from the sale or exchange of your Notes prior to a Review Date, but that could be attributed to an expected Contingent Interest Payment, could be treated as ordinary income. You should consult your tax advisor regarding this risk.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver, &amp; Jacobson LLP, is of the opinion
        that it would be reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax
        purposes as a single contingent payment debt instrument, or pursuant to some other characterization (including possible treatment as a &#8220;constructive ownership transaction&#8221; under Section 1260 of the Code), such that the timing and character of your
        income from the Notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Section 1260</font>. Because each Reference Asset would be treated as a &#8220;pass-thru entity&#8221; for purposes of Section 1260 of the Code, it is
        possible that an investment in the Notes could be treated as a &#8220;constructive ownership transaction&#8221; within the meaning of Section 1260 of the Code. If the Notes were treated as a constructive ownership transaction certain adverse U.S. federal
        income tax consequences could apply (i.e., all or a portion of any long-term capital gain that you recognize upon the taxable disposition of your Notes could be recharacterized as ordinary income and you could be subject to an interest charge on
        deferred tax liability with respect to such recharacterized gain). We urge you to read the discussion concerning the possible treatment of the Notes as a constructive ownership transaction under &#8220;Material U.S. Federal Income Tax Consequences &#8211;
        Section 1260&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described above and under
        &#8220;Material U.S. Federal Income Tax Consequences&#8221; of the product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to Notice 2008-2, the
        IRS and the Treasury are considering whether the holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is
        possible, however, that under such guidance, holders of the Notes will ultimately be required to accrue current income in excess of any receipt of Contingent Interest Payments and this could be applied on a retroactive basis. According to the
        Notice, the IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, and whether the special &#8220;constructive ownership rules&#8221; of Section
        1260 of the Code, discussed above, should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance and potential impact of the above considerations.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">18</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: Arial;"><font style="font-style: italic;">Medicare Tax on Net Investment Income.</font> U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a
        portion of their &#8220;net investment income,&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the extent of their net investment income or
        undistributed net investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse),
        $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders
        should consult their tax advisors as to the consequences of the 3.8% Medicare tax.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Specified Foreign Financial Assets.</font> U.S. holders may be subject to reporting obligations with respect to their Notes if they do not hold
        their Notes in an account maintained by a financial institution and the aggregate value of their Notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution rules) exceeds an applicable threshold. Significant
        penalties can apply if a U.S. holder is required to disclose its Notes and fails to do so.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Backup Withholding and Information Reporting. </font>The proceeds received from a taxable disposition of the Notes will be subject to
        information reporting unless you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a
        U.S. holder) or meet certain other conditions.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Non-U.S. Holders</font>. The U.S. federal income tax treatment of the Contingent Interest Payments is unclear.<font style="font-size: 10pt;">&#160;</font><font style="font-weight: bold;">Accordingly, we will treat any Contingent Interest Payments on the Notes as subject to a 30% U.S. withholding tax. To the extent we have withholding responsibilities with respect to a Note, we intend to withhold such
          tax on any Contingent Interest Payment and we anticipate that other withholding agents would do the same.</font>&#160;<font style="font-weight: bold;">You are urged to consult your tax advisors regarding the application of the withholding tax to your
          Notes and the availability of any reduction in tax pursuant to an income tax treaty. No assurance can be given that you will be able to successfully claim a reduction in tax pursuant to an applicable income tax treaty. We will not pay any
          additional amounts in respect of any such withholding.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">If you are a non&#8209;U.S. holder, you should provide us (and/or the applicable withholding agent) with a fully completed and validly executed applicable IRS Form W&#8209;8. Subject to
        Section 897 of the Code and Section 871(m) of the Code, discussed herein, gain realized from the taxable disposition of the Notes (other than amounts or proceeds attributable to a Contingent Interest Payment or any accrued but unpaid Contingent
        Interest Payment) generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by the non&#8209;U.S. holder in the U.S., (ii) the non&#8209;U.S. holder is a non&#8209;resident alien individual and is
        present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) the non&#8209;U.S. holder has certain other present or former connections with the U.S.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Section 897</font>. We will not attempt to ascertain whether the issuer of any Reference Asset would be treated as a &#8220;United States real property
        holding corporation&#8221; (&#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the Notes should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in Section 897 of the Code.
        If any such entity and the Notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a non-U.S. holder in respect of a Note upon a taxable disposition of a Note to the U.S.
        federal income tax on a net basis and the gross proceeds from such a taxable disposition could be subject to a 15% withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of any such entity as a USRPHC
        and the Notes as USRPI.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Section 871(m)</font>. A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the
        Code on certain &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities.
        The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked
        instruments that have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has
        issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments
        that are not delta-one specified equity-linked instruments and are issued before January 1, 2027.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Based on our determination that the Notes are not &#8220;delta-one&#8221; with respect to the Reference Assets, our special U.S. tax counsel is of the opinion that the Notes should not be
        delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of
        Section 871(m) of the Code will depend on our determinations on the date the terms of the Notes are set. If withholding is required, we will not make payments of any additional amounts.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Nevertheless, after the date the terms are set, it is possible that your Notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the
        Reference Assets or your Notes, and following such occurrence your Notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or other
        tax under Section 871(m) of the Code could apply to the Notes under these rules if you enter, or have entered, into certain other transactions in respect of the Reference Assets or the Notes. If you enter, or have entered, into other transactions
        in respect of the Reference Assets or the Notes, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your Notes in the context of your other transactions.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Notes, you are urged to consult your tax advisor
        regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">19</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: Arial;"><font style="font-style: italic;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders</font>. A Note may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the Note at
        the time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax
        consequences of holding the Notes at death.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Foreign Account Tax Compliance Act. </font>The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30%
        U.S. withholding tax on &#8220;withholdable payments&#8221; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical gain income, and the gross proceeds from a
        disposition of property of a type that can produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their
        affiliates) unless the payee foreign financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain
        information about such account. FATCA also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not
        certify that they do not have any substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &#8220;withholdable
        payments&#8221;, will not apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term
        &#8220;foreign passthru payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial
        foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Investors should consult their tax advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their Notes through
        a foreign entity) under the FATCA rules.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Proposed Legislation</font>. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of Notes
        purchased after the bill was enacted to accrue interest income over the term of the Notes despite the fact that there may be no interest payments over the term of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect
        of this legislation generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Notes. You are
        urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">You are urged to consult your tax advisor concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax
        consequences of the purchase, beneficial ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD).</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">20</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will purchase the Notes from TD at the
        public offering price less a concession equal to the underwriting discount set forth on the cover page of this pricing supplement. J.P. Morgan Securities LLC , which we refer to as JPMS LLC, and JPMorgan Chase Bank, N.A. will act as placement
        agents for the Notes and, from the commission to TDS, will receive a placement fee of $10.00 for each Note they sell in this offering to accounts other than fiduciary accounts. TDS and the placement agents will forgo a commission and placement fee
        for sales to fiduciary accounts.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and
        sale of the Notes. Additionally, we or one of our affiliates will pay a fee to an unaffiliated broker-dealer for providing certain electronic platform services with respect to this offering.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">For the avoidance of doubt, the fees and commissions described on the cover of this pricing supplement will not be rebated or subject to amortization if the Notes are
        automatically called.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Delivery of the Notes will be made against payment therefor on the Issue Date, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Exchange
        Act, trades in the secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the secondary market on any date
        prior to one DTC settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative settlement arrangements to prevent a failed
        settlement of the secondary market trade.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8220;conflict of interest&#8221; in this offering within the meaning of
        Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. In addition, TD will receive the net proceeds from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121.
        This offering of the Notes will be conducted in compliance with the provisions of FINRA Rule 5121. In accordance with FINRA Rule 5121, neither TDS nor any other affiliated agent of ours is permitted to sell the Notes in this offering to an account
        over which it exercises discretionary authority without the prior specific written approval of the account holder.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We, TDS, another of our affiliates or third parties may use this pricing supplement and any document incorporated herein by reference in the initial sale of the Notes. In
        addition, we, TDS, another of our affiliates or third parties may use this pricing supplement and any document incorporated herein by reference in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the Notes from us, TDS, another of our affiliates or a third party, this pricing supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or such third party
          informs such purchaser otherwise in the confirmation of sale.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European
        Economic Area (the &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer within the
        meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended.
        Consequently no key information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore
        offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United
        Kingdom (&#8220;UK&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union
        (Withdrawal) Act 2018 (the &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that
        customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU)
        No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling
        the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">21</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The final terms for the Notes were determined on the Strike Date, based on prevailing market conditions, and are set forth in this pricing supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our appetite for
        borrowing), and several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the
        estimated profit that we or any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our obligations under
        the Notes. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our
        benchmark debt securities trade in the secondary market is expected to have had an adverse effect on the economic terms of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">On the cover page of this pricing supplement, we have provided the estimated value for the Notes. The estimated value was determined by reference to our internal pricing models
        which take into account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to
        maturity of the Notes, and our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors&#8221; herein. Because our internal funding rate generally represents a discount from the levels at which our benchmark
        debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade in the secondary market is expected, assuming all other economic terms are held
        constant, to increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; The Estimated Value of Your Notes Is Based on Our Internal Funding
        Rate.&#8221;</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Our estimated value of the Notes is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the Agent may buy or
        sell the Notes in the secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market, if any, may
        exceed our estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of
        hedging our obligations under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary reimbursement period on the
        basis of a number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably
        throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and other factors that cannot be
        predicted.</div>
      <div style="text-align: justify; font-family: Arial; font-weight: bold;">We urge you to read the &#8220;Additional Risk Factors&#8221; beginning on page P-3 of this pricing supplement.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">22</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing supplement have been executed and
        issued by TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in accordance with their terms, subject
        to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is
        sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp;
        Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion is subject to customary
        assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried,
        Frank, Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; font-family: Arial;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and when this pricing supplement has been
        attached to, and duly notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the Province of Ontario, or the laws of
        Canada applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up, moratorium and other similar
        laws of general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of equitable remedies, such as
        injunctive relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability of the indenture will be
        subject to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation
        period under that Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the assumption that the senior
        indenture has been duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary assumptions about the
        genuineness of signatures and certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">23</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Oct 21 07:24:02 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">500,000.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<!-- [WMV6][QGAgJtFMGX9wvARCFuToBQsmBcXJowFq3RN/AzuwKQDMyCr/eUetCeVCsLpxg3II2CheBh8AiSr8LCevTKyZz7E09KvJhEKU8oML0puvr69gtj4ZKTpiVhu9nj2NstG4D+N0vnCy0geygwKfTWMXBqIFwvuLjV/EVHNqeMLqfrbN3PjPA33XK2Ebu3ROeXk76hZNKcbqkYlx8+9lcFJeXKYKvPUKT+mQvDyIndxlZBrh1LMhlbVRaJCm2OeC4InHphxyymkarIcznFVE251I8mwXPaRdKm6vh9Lp9Jf4UQSlc+2WQ6QVyc4Jn8Mvh4VWiisAIVBujZu++1Gp4Hz2Q7v52fne0ITSVYuakIG2/xIydwp1fHUm2OWiMEiyDmCFQ2SnLaX16TfqPF3Ir6IIJmxpjnaNlUpd2DABnxHjrjOcLe+anw==] CSR-->
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-10-20</xbrli:startDate>
    <xbrli:endDate>2025-10-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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M%(\>_P#A8>(?_EC17!45^X_7<9_T%8G_ ,'U?_DC_2W^TLQ_Z#\;_P"%5?\
M^3/SH^+7_)5?B9_V4'QG_P"I'J5?T@?!+_@M;^RQ\-O@Q\(OAUKO@']H"[UO
MP#\,/ /@K6+K2?"OPZGTJYU7PMX4TG0M0N-,GO/BK87<VGS7=A-)9RW5C9W,
MELT;SVMO*6A3^;_XM?\ )5?B9_V4'QG_ .I'J5>?5^<9!QOGO!.;9SB<BJ8:
MG5QU6I0Q#Q.&CB$Z=+$U*D%%2DN5\S=WU6A_$?!?C1QOX,\7\:9CP37RVAB<
M[QV+P6.>8Y?3S"$J&%S3$UZ2I0J3@J<O:3ES25VUIT/[(?@I_P %B/V9OCO\
M5? _P@\(^!OCKIWB7Q_K<6@Z/?>)/#/@"ST.VO)H9IUDU.YTSXG:Q?PVP2!P
MSVNF7DH8J!"021^K%S<):VUQ=2!C';02SN$ +E(8VD8(&*J6*J0H+*"<9('-
M?PO?\$X_^3X_V:O^RD67_IOU&O[EM9_Y ^J_]@V^_P#266OZW\'N,\[XTR#-
M<PSR>&J8G"9K+"47AL/'#P5%8+#5TI0BVI2]I5G[W:RZ'^J?T2O&'C3QAX&X
MIS_C2OE]?,,IXEJ97@Y9?@*> I1PD<GR_&I5*5.<E.?M\35;FVGRM1M9(_*O
MPO\ \%>_A)XWTI->\%_LQ?MM>+]#DGFMH]9\+_!;PSK^E/<VS!;BW34=)^)=
MW9M/ Q"S1"8R1,0'52163XP_X+-? ?X>-IZ>/_V>_P!L3P,^K+<MI2>,/A/X
M-\,MJ:V1@%XVGKK7Q1LC>+:&ZM1<FV$@@-S )=AFCW:G_!%7_DQS0?\ LI'Q
M#_\ 3A:5\*_\' O_ "&/V5O^P;\9?_2KX85X>:\2\;9=X:4>/(\0X.KB*N7Y
M/C7ETLAPL:*EF>+P6&G35=8AS:I+%2G&7L[R<$FE=L^+XH\1O&;A_P"CE@O'
M&GQ]E.)S#%9%PGG#R"? ^6T\'"?$>:91E]6@L;',)5G'"QS&=6$_8)U)4XQD
MHJ3:^K;#_@NS^Q[>7<%M<>"?VA=+AE8K)J%_X-\ 26EL K,'G33/BGJ-^RD@
M(!;65P^YE)0)N=?TS^#_ ,:_@G^U7\-&\7_#77M$^(G@76!<:+K>GWNGEGM+
MLP1MJ'ASQ7X;UFV2XLKM8)XS-8:E9^1>6DT-Y:->:==6UU/_ )^-?M9_P0U^
M+6K>%/VH?$GPJ:\D_P"$:^+'P_U6:333(1"?%7@9DUW1M31#N4RV^@2>++)U
M4(9$OED=R+5$;XKP^\;N(LXXGRW(^(Z>78G 9Q7^H1K4,*\/7H8FO%PPND:L
MJ-6C5K<M&K3G3YDJOM(U/W;IU/QSP%^F=X@<6^)'#O!7B'A^'\QR3BW&K(Z>
M+P.6/+\;@<RQL'2RW2&(GA<5A,5C'2P>)H5L/[11Q/MZ==*@\/7]#_X*W?\
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9IO\ ^6'_ -^G]4?\0A_ZJ'_S$_\ X3/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $3 <4# 2(  A$! Q$!_\0
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M7_XN@#>HK!\OQ/\ \_.C?^ \O_Q='E^)_P#GYT;_ ,!Y?_BZ -ZBL'R_$_\
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MK!\OQ/\ \_.C?^ \O_Q='E^)_P#GYT;_ ,!Y?_BZ -ZBL'R_$_\ S\Z-_P"
M\O\ \71Y?B?_ )^=&_\  >7_ .+H WJ*P?+\3_\ /SHW_@/+_P#%T>7XG_Y^
M=&_\!Y?_ (N@#>HK!\OQ/_S\Z-_X#R__ !='E^)_^?G1O_ >7_XN@#>HK!\O
MQ/\ \_.C?^ \O_Q='E^)_P#GYT;_ ,!Y?_BZ -ZBL'R_$_\ S\Z-_P" \O\
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M_")Z9_STU3_P:W7_ ,<K>HH P?\ A$],_P">FJ?^#6Z_^.4?\(GIG_/35/\
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M  :W7_QRMZB@#!_X1/3/^>FJ?^#6Z_\ CE'_  B>F?\ /35/_!K=?_'*WJ*
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MO_Q5=!10!S__  DK?] +7/\ P&7_ .*H_P"$E;_H!:Y_X#+_ /%5T%% '/\
M_"2M_P! +7/_  &7_P"*H_X25O\ H!:Y_P" R_\ Q5=!10!S_P#PDK?] +7/
M_ 9?_BJ/^$E;_H!:Y_X#+_\ %5T%% '/_P#"2M_T M<_\!E_^*H_X25O^@%K
MG_@,O_Q5=!10!S__  DK?] +7/\ P&7_ .*H_P"$E;_H!:Y_X#+_ /%5T%%
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MW6-ZNUU&@7>V>/E'O7N'PNL(? O@_3](BT/6I;F*/]_/]E7+N268 Y!VAF;
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MNE[@;=%8'AG_ (2<-<?\)0=%*X'D_P!G>:#[[M_X8Q6/>:QXD\/)J&K>*9-
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MY@FNE8@[26& /E48^IZU[?HMAXGTS4+:Q@C\/Q>%[4"""*,SFX2%5P@R3M)
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M4W>DZ?.9='N)9#+;(V]Q-" QR.3@D9K;O_ OA2^M7M[KPWI#PO\ > M$4_F
M"*KW'_)6+#_L"7/_ */@KK::;3N@/./AM\+]*\,>&SI^K:=I&H7(N9I!<&U5
MR8V<E 2PSPN!CM75_P#"(>&O^A>T?_P"B_\ B:W**<YRJ2<Y;L-C#_X1#PU_
MT+VC_P#@%%_\31_PB'AK_H7M'_\  *+_ .)K<HJ0,/\ X1#PU_T+VC_^ 47_
M ,31_P (AX:_Z%[1_P#P"B_^)K<HH P_^$0\-?\ 0O:/_P" 47_Q-'_"(>&O
M^A>T?_P"B_\ B:W** ,/_A$/#7_0O:/_ . 47_Q-'_"(>&O^A>T?_P  HO\
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MU_T+VC_^ 47_ ,36Y10!A_\ "(>&O^A>T?\ \ HO_B:/^$0\-?\ 0O:/_P"
M47_Q-;E% &'_ ,(AX:_Z%[1__ *+_P")H_X1#PU_T+VC_P#@%%_\36Y10!A_
M\(AX:_Z%[1__  "B_P#B:/\ A$/#7_0O:/\ ^ 47_P 36Y10!A_\(AX:_P"A
M>T?_ , HO_B:/^$0\-?]"]H__@%%_P#$UN44 8?_  B'AK_H7M'_ / *+_XF
MC_A$/#7_ $+VC_\ @%%_\36Y10!A_P#"(>&O^A>T?_P"B_\ B:/^$0\-?]"]
MH_\ X!1?_$UN44 8?_"(>&O^A>T?_P  HO\ XFC_ (1#PU_T+VC_ /@%%_\
M$UN44 8?_"(>&O\ H7M'_P# *+_XFC_A$/#7_0O:/_X!1?\ Q-;E% '/7/A'
MPVMO(5\/Z."%)!%E'QQ_NU8\%_\ (I:-_P!><7_H(K4NO^/:7_<;^59?@O\
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M.A^;D\<\8/K71_VOK?\ T+4W_@9#_C5*X_Y*Q8?]@2X_]'P5UM '/_VOK?\
MT+4W_@9#_C1_:^M_]"U-_P"!D/\ C7044 <__:^M_P#0M3?^!D/^-']KZW_T
M+4W_ (&0_P"-=!10!S_]KZW_ -"U-_X&0_XT?VOK?_0M3?\ @9#_ (UT%% '
M/_VOK?\ T+4W_@9#_C1_:^M_]"U-_P"!D/\ C7044 <__:^M_P#0M3?^!D/^
M-']KZW_T+4W_ (&0_P"-=!10!S_]KZW_ -"U-_X&0_XT?VOK?_0M3?\ @9#_
M (UT%% '/_VOK?\ T+4W_@9#_C1_:^M_]"U-_P"!D/\ C7044 <__:^M_P#0
MM3?^!D/^-']KZW_T+4W_ (&0_P"-=!10!S_]KZW_ -"U-_X&0_XT?VOK?_0M
M3?\ @9#_ (UT%% '/_VOK?\ T+4W_@9#_C1_:^M_]"U-_P"!D/\ C7044 <_
M_:^M_P#0M3?^!D/^-']KZW_T+4W_ (&0_P"-=!10!S_]KZW_ -"U-_X&0_XT
M?VOK?_0M3?\ @9#_ (UT%% '/_VOK?\ T+4W_@9#_C1_:^M_]"U-_P"!D/\
MC7044 <__:^M_P#0M3?^!D/^-']KZW_T+4W_ (&0_P"-=!10!S_]KZW_ -"U
M-_X&0_XT?VOK?_0M3?\ @9#_ (UT%% '/_VOK?\ T+4W_@9#_C1_:^M_]"U-
M_P"!D/\ C7044 <__:^M_P#0M3?^!D/^-']KZW_T+4W_ (&0_P"-=!10!S_]
MKZW_ -"U-_X&0_XT?VOK?_0M3?\ @9#_ (UT%% '/_VOK?\ T+4W_@9#_C1_
M:^M_]"U-_P"!D/\ C7044 <__:^M_P#0M3?^!D/^-']KZW_T+4W_ (&0_P"-
M=!10!S_]KZW_ -"U-_X&0_XT?VOK?_0M3?\ @9#_ (UT%% '/_VOK?\ T+4W
M_@9#_C1_:^M_]"U-_P"!D/\ C7044 <__:^M_P#0M3?^!D/^-']KZW_T+4W_
M (&0_P"-=!10!S_]KZW_ -"U-_X&0_XT?VOK?_0M3?\ @9#_ (UT%% '-W&K
M:T8) WAN4 J<G[9#QQ]:M^#/^12T;_KSB_\ 016I=?\ 'M+_ +C?RK+\%_\
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M(_\ "&3_ /0V^)__  )B_P#C='_"&3_]#;XG_P# F+_XW0!UU%<C_P (9/\
M]#;XG_\  F+_ .-U5O/!NI>=9_9/%OB/R_._TC?<Q9\O8WW?W77=L_#- '<4
M5R/_  AD_P#T-OB?_P "8O\ XW1_PAD__0V^)_\ P)B_^-T ==17(_\ "&3_
M /0V^)__  )B_P#C='_"&3_]#;XG_P# F+_XW0!UU%</J/@W4A#']@\6^(_-
M\Z/?YES%CR]X\S'[KKMW8]\5:_X0R?\ Z&WQ/_X$Q?\ QN@#KJ*Y'_A#)_\
MH;?$_P#X$Q?_ !NC_A#)_P#H;?$__@3%_P#&Z .NHKD?^$,G_P"AM\3_ /@3
M%_\ &ZJZCX-U(11_8/%OB/S/.CW^9<Q8\O>-^/W77;G'O0!W%%<C_P (9/\
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MLZEA##$[&*!3SA0<=RQ'' 8@<5TF* "BBD8[1D\#OF@!)'6-&>1@J*,LS'
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MP4]"?RTYM$L);_[8\+>=N5V D8([+]UF0':Q&!@D$C ]*TL4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %$ @T# 2(  A$! Q$!_\0
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M^$1LO^?W5_\ P82__%4 ='17.?\ "(V7_/[J_P#X,)?_ (JC_A$;+_G]U?\
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MX1&R_P"?W5__  82_P#Q5 '1T5SG_"(V7_/[J_\ X,)?_BJ/^$1LO^?W5_\
MP82__%4 ='17.?\ "(V7_/[J_P#X,)?_ (JC_A$;+_G]U?\ \&$O_P 50!T=
M%<Y_PB-E_P _NK_^#"7_ .*H_P"$1LO^?W5__!A+_P#%4 ='17.?\(C9?\_N
MK_\ @PE_^*H_X1&R_P"?W5__  82_P#Q5 '1T5SG_"(V7_/[J_\ X,)?_BJ/
M^$1LO^?W5_\ P82__%4 ='17.?\ "(V7_/[J_P#X,)?_ (JC_A$;+_G]U?\
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MJ4I4W:2\Q)W"FR*'1D<95A@CU%.HK,9RL/@](&BEAU*\2YMXU@MY@L>8H5#
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M**2@!:*** "BC-% !1110 4444 %%%% !1112N 4444P"BBB@ HHHH ****
M"BBDH 6BBB@ HHHH 3-(3D5XW^T#\1;SPW!!X>\,B^'BF^6.>V-O )08]Y##
M')S\I[5P/A'XM^+],BU/4?&,BSV\FB27^FPF(1)/*95&T-CDJ"00.@'K79#
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MU;/BBRUJ^T](O#VKPZ3=APS3RV8N05P<KM++CG'.>U5?M7B__H#Z!_X-IO\
MY&H^U>+_ /H#Z!_X-IO_ )&I\[TVT\D%BSX6L=;L;"2+Q%K$.K71D+)/%9BV
M"K@?*5#-GG//O6/I&B^-+?6HKC4_%]G>Z<')>T31UB++S@"3S"1CCG!Z5?\
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M+G_(JVW_ &%=/_\ 2J*NUH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4444 %%%% !1110 4444 %%%% '.:Q_R.WAW_KC=_P#H*5T=<YK'_([>'?\
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M,_\ ")?]1_Q#_P"!O_V-'_")?]1_Q#_X&_\ V-=-10!S/_")?]1_Q#_X&_\
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M_")?]1_Q#_X&_P#V-=-12 YG_A$O^H_XA_\  W_[&C_A$O\ J/\ B'_P-_\
ML:Z:B@#F?^$2_P"H_P"(?_ W_P"QJEKG@?\ M#1;^R&OZ[FYMY(?WEWN7YE(
MY&.1STKLZ#33L[H#X(\!WNI_#O4O$MU=P7EKJ-E;K T F,!9C/&""0#D8.>/
M:O4_AGX(U;QI\'/%MQYMY:W.MWLUU9PRSXAG^Z=S#&3\RL-WMFO3/BY\,SX\
M\8^$[B>.-]'M//34092CLAVE N.3\P->H6-G;6-I%;64$5O;1#;'%$@1$'H
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M_P"$2_ZC_B'_ ,#?_L:Z:B@#F?\ A$O^H_XA_P# W_[&C_A$O^H_XA_\#?\
M[&NFHH YG_A$O^H_XA_\#?\ [&C_ (1+_J/^(?\ P-_^QKIJ* .9_P"$2_ZC
M_B'_ ,#?_L:/^$2_ZC_B'_P-_P#L:Z:B@#B1I/\ 9?C;0O\ B8:A>>9#<_\
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MXTU8;FYR6>?;('8A<G&3R<?W1Z53^*6NZCJWP;\ V&BZJ/M'B)[6QN)2=S2
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MM;/AS0--\-Z+;Z5HULEM8VX(CC7G&3DDGN<GK6?_ ,)OH?\ STO_ /P6W/\
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MTO\ _P %MS_\;H_X3?0_^>E__P""VY_^-T =+17-?\)OH?\ STO_ /P6W/\
M\;H_X3?0_P#GI?\ _@MN?_C= '2T5S7_  F^A_\ /2__ /!;<_\ QNC_ (3?
M0_\ GI?_ /@MN?\ XW0!TM%<U_PF^A_\]+__ ,%MS_\ &Z/^$WT/_GI?_P#@
MMN?_ (W0!TM%<U_PF^A_\]+_ /\ !;<__&Z/^$WT/_GI?_\ @MN?_C= '2T5
MS7_";Z'_ ,]+_P#\%MS_ /&Z/^$WT/\ YZ7_ /X+;G_XW0!TM%<U_P )OH?_
M #TO_P#P6W/_ ,;H_P"$WT/_ )Z7_P#X+;G_ .-T =+17-?\)OH?_/2__P#!
M;<__ !NC_A-]#_YZ7_\ X+;G_P"-T =+17-?\)OH?_/2_P#_  6W/_QNC_A-
M]#_YZ7__ (+;G_XW0!TM%<U_PF^A_P#/2_\ _!;<_P#QNC_A-]#_ .>E_P#^
M"VY_^-T =+17-?\ ";Z'_P ]+_\ \%MS_P#&Z/\ A-]#_P">E_\ ^"VY_P#C
M= '2T5S7_";Z'_STO_\ P6W/_P ;H_X3?0_^>E__ ."VY_\ C= '2T5S7_";
MZ'_STO\ _P %MS_\;H_X3?0_^>E__P""VY_^-T =+17-?\)OH?\ STO_ /P6
MW/\ \;H_X3?0_P#GI?\ _@MN?_C= '2T5S7_  F^A_\ /2__ /!;<_\ QNC_
M (3?0_\ GI?_ /@MN?\ XW0!TM%<U_PF^A_\]+__ ,%MS_\ &Z/^$WT/_GI?
M_P#@MN?_ (W0!TM%<U_PF^A_\]+_ /\ !;<__&Z/^$WT/_GI?_\ @MN?_C=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH YS6/^1V\._]<;O_ -!2NCKG-8_Y';P[_P!<;O\ ]!2NCH ****
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M .,4?VQX[_Z%'1__  >-_P#&*[2C- 'GUYXH\:VM]86LOA'2O,O7>.,KK;$
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M;76J001ZN"MS87"30WEN0$N1CA@.<9!(9?RXQ714R&)((4BA4)&BA54#  '
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %) @P# 2(  A$! Q$!_\0
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MQ/\ ] 73_P#P//\ \;H Z.BN<^W>)_\ H"Z?_P"!Y_\ C='V[Q/_ - 73_\
MP//_ ,;H Z.BN<^W>)_^@+I__@>?_C='V[Q/_P! 73__  //_P ;H Z.BN<^
MW>)_^@+I_P#X'G_XW1]N\3_] 73_ /P//_QN@#HZ*YS[=XG_ .@+I_\ X'G_
M .-T?;O$_P#T!=/_ / \_P#QN@#HZ*YS[=XG_P"@+I__ ('G_P"-T?;O$_\
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MY_\ C='V[Q/_ - 73_\ P//_ ,;H Z.BN<^W>)_^@+I__@>?_C='V[Q/_P!
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MAKM:XKP'_P C5X\_["L?_I+#7:T %%%% !1110 4444 %%%% !1110 4444
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MKF_^$[\)?]#-HO\ X'1__%4?\)WX2_Z&;1?_  .C_P#BJ .DHKF_^$[\)?\
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MKF_^$[\)?]#-HO\ X'1__%4?\)WX2_Z&;1?_  .C_P#BJ .DHKF_^$[\)?\
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MD]><DURGP=U_P7<V&MZ_JFHZ0FJ:IJL\S27\L:3&)9#Y'RL<J H4CWYKT_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 &:SM>UBST+1[K4M3G2"UMHVD=F8#. 3@9
MZDXX'>O//$7Q.BTWXT:%X0$L<=I- QNI&7[TKC,*@]NG7ON [5Y/INL7O[0W
MC*VT37;>32=!T^&:^V6DI6256*K&3N!5B#W _B.*[*6#G)<\](VN_0ER6R+?
MPP4_%[XSW?C2XA_L^WT=+<FQ=O,,C%'"')&, KNZ=2,4?"_X/:UX0^,-I%J]
MO%JNB+9RSFZ$1,"NPVA2&XWYQQUQS7O/A'P1H_A34-5O-)299=2,/FAWW*JQ
M)L15'8 9]3SUZ5T^*TJ8]WE&E\+25OZ\[B4>YYA\,[B#1?&?COP],YM\:HE[
M;))+E66YCW83)SDM'(Q ]:XSXY6VH>*_B]X0\(&>Z_L":)9[Z&#=M(,C9\S!
MZ$1@ GIDD5E?&U;W2/CMH6LZ4HV6\%I>7H/("^>T 8CO@2$>V:]!^&1N]2^+
M'Q'U2YD\^U@GM]-M9-P(4(I9T&/0LI^IK5+V-L2GO'\=O^"&^AZ%X8T'3O#.
MBV^DZ+;BWL+<$1Q[BV,DDY)Y/)[UJGH:*&Z&O+;<G=EG.?#O_D2M)_ZY?^S&
MNCKG/AW_ ,B5I/\ UR_]F-='2 **#TK \0>(4T?4-/M#%$[W@<JTMRD*C:5&
M 6ZL=XP!Z&@#?HKF1XJC D9[.8*P8VIW _:,2+&?]WYF7KV.>U:^CZA_:%J[
MM$T$T4C0RQ,0VQQU&1P?K0!S/@/_ )&KQY_V%8__ $EAKM:XOP("/%/CS_L*
MQ_\ I+#7:4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 444C=,G]: #-<'\8/B#I_@'PS--=3E=3NXI4T^()N+RA>"
M1TV@E<D^M>3>,?$GC/XF>)]8T_P(UU:Z)H6^2*]M6V_:;F,'"[^X)R HST!-
M7?AP]C\9?%?]H>(&EO[+PU8V26\3KL5KMQNFD;!Y^:+&#P1VKOAA%32J5=EN
MENNWWDN71&3X]^$B^#_A7::_8W)?Q'I4\&IW5S>-YK950#%&<#Y Y# '/3K7
MI7P7^']GH$.F^(X[J>2XO-#M;;R9% $8VAVY[Y..PQCO79?$3PXWBWP5JNA1
MW"VS7L0C$K+N"?,#T_"MZU@2VMXH8E"QQH$4#L ,"HJ8N=2ERMZW?W?U<%%)
MDM%%%<91YG^T!86I^%OB>_-O']M6R6(7&T;P@E5MN>N,\XJE^S+<F_\ AF=0
MDC1)[S4;NXEVCJS2$_CUQ6Q^T!_R1OQ3_P!>P_\ 0UK2^%/A$^"/ VGZ'),D
M\T&]I)8U(5V9B20#SW%=O.OJG*]^;]-?T)^T=?0W0T4'H:XBCG/AW_R)6D_]
M<O\ V8UT=<Y\._\ D2M)_P"N7_LQKHZ "LKQ!IMSJMFUG%=0P6LZ-'<AX#(S
MH>"%.X!3C/)#=?:M6B@#EE\)'84:^RD*LMEB'F',BR?/\WS_ #(HXV\9'4YK
M6TS2OLUC<0W4HN)+EWDG94V*S-UP,D@8XZD^]:=% 'E?@OP=H-QXD\:QRV *
M0:G&D8\Z08'V:$_WO4FNN_X03PY_T#O_ "/)_P#%5E^ VE_X3+Q^IC40#4H2
MLF[DM]FBW#'8 !3GOD^E63JOC;^W/)'AK2CI/G[/M/\ :A\SRLXW[/+ZXYVY
M]LU2BV!;_P"$$\.?] [_ ,CR?_%4?\()X<_Z!W_D>3_XJI_%5[XBM$M_^$9T
MFRU)V+><+J\-N$'&,81LYY].E3Z/=:U-H1GU73;6UU;:Y%K#=>;&2,[1YFT=
M>,\<>]'*[7 H_P#"">'/^@=_Y'D_^*H_X03PY_T#O_(\G_Q50>'-3\8W6IB/
MQ!X>TRPL=A)FM]2,[!NPVF->#ZYI?$FI^,+74C'X>\/:9J%EL!\ZYU(P,6[C
M;Y;<>^:?([VNOO0KDW_"">'/^@=_Y'D_^*H_X03PY_T#O_(\G_Q57M6N]:AT
M$3Z9IMM<ZL50FUENO+C#'&X>9M/3G''-5_"M]XBNUN?^$GTBRTUE*^3]EO3<
M"0<YSE%QCCUSFERZ7&0_\()X<_Z!W_D>3_XJC_A!/#G_ $#O_(\G_P 550ZK
MXV_MWR1X:THZ3Y^S[3_:A\SRL_?V>7UQSMS^-:7BJ]\16D=N?#.D66INQ;SA
M=7AMP@XQC"-G//ITI\CNE=?>!!_P@GAS_H'?^1Y/_BJ/^$$\.?\ 0._\CR?_
M !57M'NM:FT(SZKIUK:ZJ ^+6&Y\V,D9V_O-HZ\=N*RO#>I^,;K4EC\0>'M,
ML+$H29K?4C.P;L-OEKP?7-+D>OD*Y/\ \()X<_Z!W_D>3_XJC_A!/#G_ $#O
M_(\G_P 54/B34_&-KJ1C\/>'M,U"RV ^=<:D8&+=QM$;<#US6IJUWK,.@B?3
M-.MKG5RJ$VDMUY<8)QN'F;3TY[<T<CT\QE'_ (03PY_T#O\ R/)_\51_P@GA
MS_H'?^1Y/_BJF\*WOB*[2Y_X2?2++3&4KY(M;TW <<YSE%QCCUZUG-JOC8:[
MY(\-:5_97G[/M/\ :A\SRL_?V>7UQSMS[9I\CNU=?>!;_P"$$\.?] [_ ,CR
M?_%4?\()X<_Z!W_D>3_XJI_%5[XBLX[;_A&=(LM2=BWG"ZO#;A!QC'R-G//Y
M5/H]WK4VA&?5=-MK75@'Q:PW7FQDC.T>9M'7CMQ2Y=+@4?\ A!/#G_0._P#(
M\G_Q5'_"">'/^@=_Y'D_^*J#PWJ?C&ZU)8_$'A[3+"Q*$F>WU(SL&[#:8UX]
M\TOB34_&%MJ1C\/>'M,O[+8#YUSJ1@<MW&T1MP/7-/D=[77WH+DW_"">'/\
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M $EAKM<5Q7@/_D:O'G_85C_])8:[6@ HHHH ,4444 &**** #%%%% !1110
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MB*.:)N&210RGZ@UA#%2A651;)WL-QTL?'NAW%YX\\)Z!\)G::QUC3M2D%VS
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M_P"$/MO^@KX@_P#!K/\ _%5TM% '-?\ "'VW_05\0?\ @UG_ /BJ/^$/MO\
MH*^(/_!K/_\ %5TM% '-?\(?;?\ 05\0?^#6?_XJC_A#[;_H*^(/_!K/_P#%
M5TM% '-?\(?;?]!7Q!_X-9__ (JC_A#[;_H*^(/_  :S_P#Q5=+10!S7_"'V
MW_05\0?^#6?_ .*H_P"$/MO^@KX@_P#!K/\ _%5TM% '-?\ "'VW_05\0?\
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M-9__ (JNEHH YK_A#[;_ *"OB#_P:S__ !5'_"'VW_05\0?^#6?_ .*KI:*
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M(P=OLT/('V@;1C QD],YYP.O^Q>+?^@[HG_@GE_^2:SO ?\ R-7CS_L*Q_\
MI+#7:T <W]B\6_\ 0=T3_P $\O\ \DT?8O%O_0=T3_P3R_\ R37244 <W]B\
M6_\ 0=T3_P $\O\ \DT?8O%O_0=T3_P3R_\ R37244 <W]B\6_\ 0=T3_P $
M\O\ \DT?8O%O_0=T3_P3R_\ R37244 <W]B\6_\ 0=T3_P $\O\ \DT?8O%O
M_0=T3_P3R_\ R37244 <W]B\6_\ 0=T3_P $\O\ \DT?8O%O_0=T3_P3R_\
MR37244 <W]B\6_\ 0=T3_P $\O\ \DU%=1>)K2W>>[\1Z!!!&,O))I,BJH]2
M3<X%='>W4-E9SW5W(L5O!&TLDC'A%49)/L *\0\7^+[/XLWUGX*\)3W3Z5=2
M-+JNHK;LL?V>, [(V8<EFP,\=.^:UI4G4?EU8F['J"VGBQE!77M$(/((T>3G
M_P F:7[%XM_Z#VB?^">3_P"2:^;_  A\6_&]IIOABY:SCM_!U@(+&]O)H<I*
M-XC9M_4%01P.?ER<UZ1JWQUBO-6_LSX?Z*_B6]1YO,1)O*S'&BMYB<'<#N(
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M D4&<[1N'7. 1C.><#'->R/!$\T<KQ1M+&"$<J"RYZX/;-28Z4>UI+:'WO\
MX8+,\E@^$EQX@L4G^(/B36M1U&8;I[:UNO)M(P6#&-$ Y7'RG/;I@\UZG865
MOI]C!9V,$=O:0((XHHUVJBCH *LT5G.K*II)Z#2L<M/X#\.S^%[SP[)IRG2+
MN9[B6 .P^=WWDJ<Y7YNF.G:KOACPMHOABP@M-$T^"VCAC\I7"YD*YS@N?F//
MJ:W**3J3:Y6] "C%%%0!3O--L;QBUY96UPQ4*3+$KY .0.1TSS]:^=O"^AG6
M_CMK'AZ;3Q+X4T._GU)K=L^2LTJ1[ 5^Z?F#L![MZ5]*FLNQT'3['6]2U:U@
M\N_U)8ENI Q_>",$)QT& QZ=:WHU_9*2[K3R$U<T8HTBC6.)%1% 5548"@=
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M* .9_MCQ'_T*W_E1C_PH_MCQ'_T*W_E1C_PKIJ* .9_MCQ'_ -"M_P"5&/\
MPH_MCQ'_ -"M_P"5&/\ PKIJ* .9_MCQ'_T*W_E1C_PH_MCQ'_T*W_E1C_PK
MIJ* .9_MCQ'_ -"M_P"5&/\ PH_MCQ'_ -"M_P"5&/\ PKIJ* .9_MCQ'_T*
MW_E1C_PH_MCQ'_T*W_E1C_PKIJ* .9_MCQ'_ -"M_P"5&/\ PH_MCQ'_ -"M
M_P"5&/\ PKIJ* .9_MCQ$?\ F5O_ "HQ_P"%']L>(O\ H5O_ "HQ_P"%=-10
M!S/]L>(_^A6_\J,?^%']L>(_^A6_\J,?^%=-10!S/]L>(_\ H5O_ "HQ_P"%
M']L>(_\ H5O_ "HQ_P"%=-10!S/]L>(_^A6_\J,?^%']L>(_^A6_\J,?^%=-
M10!S/]L>(_\ H5O_ "HQ_P"%']L>(_\ H5O_ "HQ_P"%=-10!S/]L>(_^A6_
M\J,?^%']L>(_^A6_\J,?^%=-10!S/]L>(_\ H5O_ "HQ_P"%']L>(_\ H5O_
M "HQ_P"%=-10!S/]L>(_^A6_\J,?^%']L>(_^A6_\J,?^%=-10!S/]L>(_\
MH5O_ "HQ_P"%']L>(_\ H5O_ "HQ_P"%=-10!S/]L>(_^A6_\J,?^%']L>(_
M^A6_\J,?^%=-10!S/]L>(_\ H5O_ "HQ_P"%']L>(_\ H5O_ "HQ_P"%=-10
M!S/]L>(_^A6_\J,?^%']L>(_^A6_\J,?^%=-10!S/]L>(_\ H5O_ "HQ_P"%
M']L>(_\ H5O_ "HQ_P"%=-10!S/]L>(_^A6_\J,?^%']L>(_^A6_\J,?^%=-
M10!S/]L>(_\ H5O_ "HQ_P"%']L>(_\ H5O_ "HQ_P"%=-10!S/]L>(_^A6_
M\J,?^%']L>(_^A6_\J,?^%=-10!S/]L>(_\ H5O_ "HQ_P"%!UCQ%C_D5O\
MRHQ_X5TU#=#0!SGP[_Y$K2?^N7_LQKHZYSX=_P#(E:3_ -<O_9C71T %%%&:
M "BC-)F@#B_ ?_(U>//^PK'_ .DL-=K7%> _^1J\>?\ 85C_ /26&NUH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\)GI7_/'6_\ P27O_P :H_X3/2O^>.M_^"2]_P#C5=)10!S?_"9Z5_SQUO\
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M+HPVD+BYG:Y;?&IPS8R!QTXJ[_9>G_\ /C:?]^5_PH P_P#A87@S_H;- _\
M!C%_\51_PL+P9_T-F@?^#&+_ .*K<_LO3_\ GQM/^_*_X4?V7I__ #XVG_?E
M?\* ,/\ X6%X,_Z&S0/_  8Q?_%4?\+"\&?]#9H'_@QB_P#BJW/[+T__ )\;
M3_ORO^%-?3=.12S65FJCJ3$H _2@#$_X6'X,_P"ALT#_ ,&,7_Q5+_PL+P9_
MT-F@?^#&+_XJK^F^'-+L/M7DVD+_ &FX>X;?&IPS8R!QTXJ[_9>G_P#/C:?]
M^5_PH P_^%A>#/\ H;- _P#!C%_\51_PL+P9_P!#9H'_ (,8O_BJW/[+T_\
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MO3_^?&T_[\K_ (4 8?\ PL+P9_T-F@?^#&+_ .*H_P"%A>#/^ALT#_P8Q?\
MQ5;G]EZ?_P ^-I_WY7_"C^R]/_Y\;3_ORO\ A0!A_P#"PO!G_0V:!_X,8O\
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M+)*A>X,H#,1R. ,<# QQ@=ZZ+%&** "BBB@"KJ%_;:=:FXO)1%$"%S@DDGH
M!R2>P')KE=2U>'7Y)8]+U==/_L]HYQ*9-GF/S^[D0X.SLW0YX[5OZ]I\][#;
MR64B1WEK,)XO,!*,0""K8YP03R.1UJAH^AF35;K5M9LK$7LQ3RTC'F>5M&-V
M\@'<>,XQPJ^E #]+T.*X73[S6+5CJ-H9"ADN/.P7();. #]T8XXP,8KH:**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 20, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$500,000.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 6
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-038797-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-038797-xbrl.zip
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A:6YG9F5E<RYH=&U02P4&      $  0 ^    :@@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-10-20</startDate>
            <endDate>2025-10-20</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$500,000.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">500000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
